candidate_genes,disease,celltype,y,user_question,full_query
"['FRY', 'CALHM5', 'CD3E', 'LINC02054', 'OR8D4']",rheumatoid arthritis,effector memory cd4 positive alpha beta t cell,CD3E,"Which gene among FRY, CALHM5, CD3E, LINC02054, and OR8D4 exhibits the highest cell-type specificity in effector memory CD4+ αβ T cells relevant to rheumatoid arthritis?","Which gene among FRY, CALHM5, CD3E, LINC02054, and OR8D4 exhibits the highest cell-type specificity in effector memory CD4+ αβ T cells relevant to rheumatoid arthritis? Identify the verified therapeutic targets for rheumatoid arthritis and extract their cell-type–specific embeddings from PINNACLE. Next, determine which genes activated in effector memory CD4+ αβ T cells overlap with these therapeutic targets to produce a set of cell-type–specific targets. Compute the average embedding for this overlapping set and calculate the cosine similarity between this reference and the embedding for each individual target gene. If one gene exhibits a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance in rheumatoid arthritis."
"['ARMCX2', 'IL6ST', 'PYHIN1', 'NADSYN1', 'C10orf67']",rheumatoid arthritis,effector memory cd4 positive alpha beta t cell,IL6ST,"Among the following genes—ARMCX2, IL6ST, PYHIN1, NADSYN1, and C10orf67—which one exhibits the highest cell-type specificity in effector memory CD4+ αβ T cells relevant to rheumatoid arthritis targeting?","Among the following genes—ARMCX2, IL6ST, PYHIN1, NADSYN1, and C10orf67—which one exhibits the highest cell-type specificity in effector memory CD4+ αβ T cells relevant to rheumatoid arthritis targeting? Identify validated therapeutic targets for rheumatoid arthritis and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine which genes from the effector memory CD4+ alpha–beta T cell activation set overlap with these targets, defining the cell-type–specific RA targets. Compute the average embedding for this overlapping set and calculate the cosine similarity between this average and each individual target embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['ZNF696', 'PRKD2', 'VPS39-DT', 'COX4I1', 'ATP6V0B']",rheumatoid arthritis,effector memory cd4 positive alpha beta t cell,COX4I1,"Which gene—ZNF696, PRKD2, VPS39-DT, COX4I1, or ATP6V0B—exhibits the highest cell-type specificity in effector memory CD4+ αβ T cells for targeting rheumatoid arthritis?","Which gene—ZNF696, PRKD2, VPS39-DT, COX4I1, or ATP6V0B—exhibits the highest cell-type specificity in effector memory CD4+ αβ T cells for targeting rheumatoid arthritis? Identify validated therapeutic targets for rheumatoid arthritis and retrieve their cell-type–specific embeddings from the PINNACLE database. Then, intersect these targets with the set of effector memory CD4+ αβ T cell-activated genes available in PINNACLE. Next, calculate the average embedding of the overlapping genes to serve as a reference and compute the cosine similarity between this reference and each individual overlapping target. Finally, if one gene demonstrates a markedly higher similarity compared to the others, nominate it as the top candidate, and provide a concise, evidence-based rationale for its biological relevance."
"['NT5C', 'TCEA2', 'KHNYN', 'PRDM1', 'LL22NC03-63E9.3']",rheumatoid arthritis,effector memory cd4 positive alpha beta t cell,PRDM1,"Which gene among NT5C', TCEA2, KHNYN, PRDM1, and LL22NC03-63E9.3 exhibits the highest specificity in effector memory CD4+αβ T cells and is most promising as a therapeutic target for rheumatoid arthritis?","Which gene among NT5C', TCEA2, KHNYN, PRDM1, and LL22NC03-63E9.3 exhibits the highest specificity in effector memory CD4+αβ T cells and is most promising as a therapeutic target for rheumatoid arthritis? Identify the verified therapeutic targets for rheumatoid arthritis and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine the overlap between these targets and the effector memory CD4+ αβ T-cell activated genes in PINNACLE to define cell-type–specific targets for rheumatoid arthritis. Calculate the average embedding for this overlapping set and compute the cosine similarity between the average and each individual target's embedding. If one gene shows markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MIR223HG', 'CABP5', 'ACSBG1', 'LTB', 'TFDP1']",rheumatoid arthritis,effector memory cd4 positive alpha beta t cell,LTB,"Which gene among MIR223HG, CABP5, ACSBG1, LTB, and TFDP1 exhibits the highest specificity to effector memory CD4+ αβ T cells in the context of rheumatoid arthritis?","Which gene among MIR223HG, CABP5, ACSBG1, LTB, and TFDP1 exhibits the highest specificity to effector memory CD4+ αβ T cells in the context of rheumatoid arthritis? Identify the validated therapeutic targets for rheumatoid arthritis and obtain their cell-type–specific embeddings from PINNACLE. Among these targets, determine the overlap with effector memory CD4+ alpha-beta T cell-activated genes available in PINNACLE. Calculate the average embedding for this overlapping set and compute the cosine similarity between this average reference and the embedding for each individual target. If one gene exhibits a significantly higher cosine similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['UQCC3', 'SMYD2', 'JAK3', 'REEP1', 'PACSIN3']",rheumatoid arthritis,effector memory cd4 positive alpha beta t cell,JAK3,"Which gene among UQCC3, SMYD2, JAK3, REEP1, and PACSIN3 exhibits the highest cell-type specificity in effector memory CD4+ αβ T cells, making it the most promising target for rheumatoid arthritis therapy?","Which gene among UQCC3, SMYD2, JAK3, REEP1, and PACSIN3 exhibits the highest cell-type specificity in effector memory CD4+ αβ T cells, making it the most promising target for rheumatoid arthritis therapy? Identify the experimentally validated therapeutic targets for rheumatoid arthritis and extract their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the genes activated in effector memory CD4+ alpha–beta T cells in PINNACLE. Using this overlapping set as the cell-type–specific targets for rheumatoid arthritis, compute their average embedding and calculate the cosine similarity between this reference embedding and each individual gene embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['KLHDC10', 'PPIAL4H', 'NOL12', 'ABI3BP', 'RPL21']",rheumatoid arthritis,effector memory cd4 positive alpha beta t cell,RPL21,"Among the genes KLHDC10, PPIAL4H, NOL12, ABI3BP, and RPL21, which one exhibits the highest expression specificity in effector memory CD4+ αβ T cells relevant for rheumatoid arthritis targeting?","Among the genes KLHDC10, PPIAL4H, NOL12, ABI3BP, and RPL21, which one exhibits the highest expression specificity in effector memory CD4+ αβ T cells relevant for rheumatoid arthritis targeting? Identify validated therapeutic targets for rheumatoid arthritis and obtain their cell-type–specific embeddings from PINNACLE. Next, identify which of these targets overlap with the effector memory CD4+ alpha-beta T cell–activated genes in PINNACLE. Calculate the mean embedding for this overlapping set, then compute the cosine similarity between this average embedding and the embedding of each individual target. If one gene shows a distinctly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MT-ND3', 'ARPC3', 'TXNDC2', 'MEMO1', 'GNA13']",rheumatoid arthritis,effector memory cd4 positive alpha beta t cell,MT-ND3,"Among the genes MT-ND3, ARPC3, TXNDC2, MEMO1, and GNA13, which one exhibits the highest cell-type specificity in effector memory CD4+ αβ T cells for potential targeting in rheumatoid arthritis?","Among the genes MT-ND3, ARPC3, TXNDC2, MEMO1, and GNA13, which one exhibits the highest cell-type specificity in effector memory CD4+ αβ T cells for potential targeting in rheumatoid arthritis? Identify the validated therapeutic targets for rheumatoid arthritis and extract their cell-type–specific embeddings from PINNACLE. Then, determine the overlap between these targets and the effector memory CD4⁺ αβ T-cell activated genes in PINNACLE to define the cell-type–specific targets for rheumatoid arthritis. Compute the average embedding of this overlapping set as a reference, and calculate the cosine similarity between this reference and the embedding of each individual gene. If one gene shows a substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ZNF385D', 'ADAMTS2', 'TNFAIP3', 'C12orf57', 'TAF5']",rheumatoid arthritis,effector memory cd4 positive alpha beta t cell,TNFAIP3,"Which gene, among ZNF385D, ADAMTS2, TNFAIP3, C12orf57, and TAF5, shows the highest specificity for effector memory CD4+ αβ T cells in the context of rheumatoid arthritis?","Which gene, among ZNF385D, ADAMTS2, TNFAIP3, C12orf57, and TAF5, shows the highest specificity for effector memory CD4+ αβ T cells in the context of rheumatoid arthritis? Identify the verified therapeutic targets for rheumatoid arthritis and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which genes from PINNACLE’s activated effector memory CD4+ αβ T cell profile overlap with these targets, thereby defining the cell-type–specific targets for rheumatoid arthritis. Compute the average embedding for this overlapping set and then calculate the cosine similarity between this reference embedding and each individual gene. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['EPB41L4A-DT', 'GAR1', 'TMEM256', 'TRPC4AP', 'HLA-A']",rheumatoid arthritis,effector memory cd4 positive alpha beta t cell,HLA-A,"Which gene among EPB41L4A-DT, GAR1, TMEM256, TRPC4AP, and HLA-A exhibits the highest cell-type specificity in effector memory CD4+ αβ T cells, making it the best candidate for targeting rheumatoid arthritis?","Which gene among EPB41L4A-DT, GAR1, TMEM256, TRPC4AP, and HLA-A exhibits the highest cell-type specificity in effector memory CD4+ αβ T cells, making it the best candidate for targeting rheumatoid arthritis? Which validated therapeutic targets for rheumatoid arthritis can be identified and retrieved from the PINNACLE dataset with cell-type–specific embeddings, and how do these overlap with the effector memory CD4+ αβ T cell-activated genes in the same dataset? Calculate the average embedding of the overlapping genes, then compute the cosine similarity between this reference and each individual target. If one gene exhibits a significantly higher similarity, nominate it as the primary candidate and provide a concise, evidence-based rationale for its biological relevance."
"['EDC4', 'HMG20B', 'DCTN6', 'S100A10', 'PKD2L1']",rheumatoid arthritis,effector memory cd4 positive alpha beta t cell,S100A10,"Which gene, among EDC4, HMG20B, DCTN6, S100A10, and PKD2L1, demonstrates the highest cell-type specificity in effector memory CD4+ αβ T cells for targeted intervention in rheumatoid arthritis?","Which gene, among EDC4, HMG20B, DCTN6, S100A10, and PKD2L1, demonstrates the highest cell-type specificity in effector memory CD4+ αβ T cells for targeted intervention in rheumatoid arthritis? For rheumatoid arthritis, first identify the verified therapeutic target genes and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the effector memory CD4+ αβ T cell-activated genes present in PINNACLE, thereby defining the cell-type–specific therapeutic targets. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between this reference and the embedding of each individual target gene. If one gene exhibits a distinctly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based justification for its biological relevance."
"['SDCBP2-AS1', 'TMEM184C', 'RPL3', 'TET1', 'NOP53-AS1']",rheumatoid arthritis,effector memory cd4 positive alpha beta t cell,RPL3,"Among SDCBP2-AS1, TMEM184C, RPL3, TET1, and NOP53-AS1, which gene demonstrates the highest cell-type specificity in effector memory CD4+ αβ T cells for potential targeting in rheumatoid arthritis?","Among SDCBP2-AS1, TMEM184C, RPL3, TET1, and NOP53-AS1, which gene demonstrates the highest cell-type specificity in effector memory CD4+ αβ T cells for potential targeting in rheumatoid arthritis? Identify validated therapeutic targets for rheumatoid arthritis and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which effector memory CD4⁺ αβ T cell-activated genes in PINNACLE intersect with these targets, thereby defining the cell-type–specific rheumatoid arthritis targets. Compute the average embedding for this overlapping set and calculate the cosine similarity between this reference and each individual target embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate, providing a concise, evidence-based rationale for its biological relevance."
"['TRDV3', 'CD2', 'SNX31', 'TBPL2', 'SYNC']",rheumatoid arthritis,effector memory cd4 positive alpha beta t cell,CD2,"Which gene among TRDV3, CD2, SNX31, TBPL2, and SYNC exhibits the greatest specificity in effector memory CD4⁺ αβ T cells for targeted interventions in rheumatoid arthritis?","Which gene among TRDV3, CD2, SNX31, TBPL2, and SYNC exhibits the greatest specificity in effector memory CD4⁺ αβ T cells for targeted interventions in rheumatoid arthritis? Identify the validated therapeutic targets for rheumatoid arthritis and retrieve their cell‐type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with the effector memory CD4+ alpha‐beta T cell–activated genes available in PINNACLE, as these overlapping genes represent the cell‐type–specific targets. Compute the average embedding of this overlapping set as a reference, and then calculate the cosine similarity between this reference and each individual target embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MYO3A', 'RPLP1', 'LINC01806', 'ZNF865', 'CD8B2']",rheumatoid arthritis,effector memory cd4 positive alpha beta t cell,RPLP1,"Among the genes MYO3A, RPLP1, LINC01806, ZNF865, and CD8B2, which one exhibits the highest cell-type specificity in effector memory CD4+ αβ T cells for targeting rheumatoid arthritis?","Among the genes MYO3A, RPLP1, LINC01806, ZNF865, and CD8B2, which one exhibits the highest cell-type specificity in effector memory CD4+ αβ T cells for targeting rheumatoid arthritis? Identify the validated therapeutic targets for rheumatoid arthritis and obtain their cell-type-specific embeddings from PINNACLE. Then, find the overlap between these targets and the effector memory CD4+ alpha-beta T cell-activated genes in PINNACLE to define the cell-type-specific target set. Calculate the average embedding for this set and determine the cosine similarity between this reference and each individual target. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise evidence-based rationale for its biological relevance."
"['CORO1A', 'OPHN1', 'CCDC175', 'ZNF18', 'TMEM213']",rheumatoid arthritis,effector memory cd4 positive alpha beta t cell,CORO1A,"Among the following genes—CORO1A, OPHN1, CCDC175, ZNF18, and TMEM213—which exhibits the highest cell-type specificity in effector memory CD4+ alpha beta T cells, thereby representing the most promising target for rheumatoid arthritis?","Among the following genes—CORO1A, OPHN1, CCDC175, ZNF18, and TMEM213—which exhibits the highest cell-type specificity in effector memory CD4+ alpha beta T cells, thereby representing the most promising target for rheumatoid arthritis? Identify the validated therapeutic targets for rheumatoid arthritis and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine the overlapping genes between these targets and the effector memory CD4+ αβ T cell‐activated gene set in PINNACLE. Using this overlapping set as the cell-type–specific targets for rheumatoid arthritis, calculate their average embedding and then compute the cosine similarity between this average and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['GPSM3', 'LINC00628', 'TIPRL', 'SH3RF3', 'SUCLG1']",rheumatoid arthritis,effector memory cd4 positive alpha beta t cell,GPSM3,"Which gene among GPSM3, LINC00628, TIPRL, SH3RF3, and SUCLG1 exhibits the highest cell-type specificity in effector memory CD4⁺ αβ T cells relevant to rheumatoid arthritis targeting?","Which gene among GPSM3, LINC00628, TIPRL, SH3RF3, and SUCLG1 exhibits the highest cell-type specificity in effector memory CD4⁺ αβ T cells relevant to rheumatoid arthritis targeting? Identify the validated therapeutic targets for rheumatoid arthritis and obtain their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the gene set representing activated effector memory CD4+ αβ T cells in PINNACLE. Define this intersection as the cell-type–specific targets for rheumatoid arthritis. Calculate the average embedding for these genes and then compute the cosine similarity between this average and each individual target embedding. If one gene exhibits a significantly higher similarity score than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PRICKLE3', 'LINC00278', 'CD52', 'TRIM56', 'ACYP2']",rheumatoid arthritis,effector memory cd4 positive alpha beta t cell,CD52,"Which gene—PRICKLE3, LINC00278, CD52, TRIM56, or ACYP2—exhibits the highest expression specificity in effector memory CD4+ αβ T cells, making it the most promising single target for rheumatoid arthritis intervention?","Which gene—PRICKLE3, LINC00278, CD52, TRIM56, or ACYP2—exhibits the highest expression specificity in effector memory CD4+ αβ T cells, making it the most promising single target for rheumatoid arthritis intervention? Determine which therapeutic targets for rheumatoid arthritis, validated in current literature, are represented in PINNACLE. Next, using the cell-type–specific embeddings, identify the overlap between these targets and the genes activated in effector memory CD4+ αβ T cells. For the overlapping targets, compute their average embedding to generate a reference profile, then calculate the cosine similarity between this reference and each individual target. If one gene displays a substantially higher similarity relative to the others, nominate it as the top candidate and provide a concise evidence-based rationale for its biological relevance in rheumatoid arthritis."
"['ECPAS', 'ZBED5-AS1', 'LINC02384', 'DDX6', 'CNN3']",rheumatoid arthritis,effector memory cd4 positive alpha beta t cell,DDX6,"Which gene among ECPAS, ZBED5-AS1, LINC02384, DDX6, and CNN3 exhibits the highest specificity for effector memory CD4+ αβ T cells, making it the most promising target for rheumatoid arthritis intervention?","Which gene among ECPAS, ZBED5-AS1, LINC02384, DDX6, and CNN3 exhibits the highest specificity for effector memory CD4+ αβ T cells, making it the most promising target for rheumatoid arthritis intervention? Identify the validated therapeutic targets for rheumatoid arthritis and obtain their corresponding cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the effector memory CD4+ alpha-beta T-cell activated genes present in PINNACLE to define the cell-type–specific targets for rheumatoid arthritis. Compute the average embedding of these overlapping targets as a reference, then calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate that gene as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['PRR19', 'LINC02851', 'PPIA', 'PTCRA', 'TCF25']",rheumatoid arthritis,effector memory cd4 positive alpha beta t cell,PPIA,"Which gene among PRR19, LINC02851, PPIA, PTCRA, and TCF25 exhibits the highest cell-type specificity in effector memory CD4+ αβ T cells for targeting rheumatoid arthritis?","Which gene among PRR19, LINC02851, PPIA, PTCRA, and TCF25 exhibits the highest cell-type specificity in effector memory CD4+ αβ T cells for targeting rheumatoid arthritis? Using the verified therapeutic targets for rheumatoid arthritis, retrieve their cell-type–specific embeddings from the PINNACLE database. Then, identify which of these targets overlap with the set of effector memory CD4+ alpha-beta T cell activated genes in PINNACLE, defining the cell-type–specific targets for rheumatoid arthritis. Next, compute the average embedding of this overlapping group to create a reference vector, and calculate the cosine similarity between this reference and each individual target. If one gene shows a distinctly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['KRTAP5-2', 'HLA-C', 'CSTF2T', 'ATXN2L', 'TTLL12']",rheumatoid arthritis,effector memory cd4 positive alpha beta t cell,HLA-C,"Which gene among KRTAP5-2, HLA-C, CSTF2T, ATXN2L, and TTLL12 exhibits the highest cell-type specificity in effector memory CD4+ αβ T cells for targeting rheumatoid arthritis?","Which gene among KRTAP5-2, HLA-C, CSTF2T, ATXN2L, and TTLL12 exhibits the highest cell-type specificity in effector memory CD4+ αβ T cells for targeting rheumatoid arthritis? Identify the therapeutic targets for rheumatoid arthritis with confirmed validity and retrieve their cell-type-specific embeddings from the PINNACLE database. Next, determine the overlap between these targets and the genes activated in effector memory CD4+ αβ T cells within PINNACLE, considering this intersection as the set of RA cell-type-specific targets. Compute the average embedding for this overlapping set and assess each individual target's similarity by calculating the cosine similarity to this reference embedding. Finally, if one gene displays markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['HIF1A', 'TM2D2', 'FAM193B-DT', 'LRP1', 'MRM3']",rheumatoid arthritis,classical monocyte,HIF1A,"Which gene among HIF1A, TM2D2, FAM193B-DT, LRP1, and MRM3 shows the highest cell-type specificity in classical monocytes, making it the most promising target for rheumatoid arthritis?","Which gene among HIF1A, TM2D2, FAM193B-DT, LRP1, and MRM3 shows the highest cell-type specificity in classical monocytes, making it the most promising target for rheumatoid arthritis? Identify the verified therapeutic targets for rheumatoid arthritis and obtain their cell-type–specific gene embeddings from PINNACLE. Next, determine which of these targets overlap with classical monocyte-activated genes in PINNACLE, and compute the average embedding for this overlapping set. Then, calculate the cosine similarity between the reference embedding and each individual overlapping gene. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['IFNGR2', 'LACTB2-AS1', 'GBP7', 'JARID2', 'TRAF3IP1']",rheumatoid arthritis,classical monocyte,IFNGR2,"Among these genes—IFNGR2, LACTB2-AS1, GBP7, JARID2, and TRAF3IP1—which one exhibits the highest cell-type specificity in classical monocytes in the context of rheumatoid arthritis?","Among these genes—IFNGR2, LACTB2-AS1, GBP7, JARID2, and TRAF3IP1—which one exhibits the highest cell-type specificity in classical monocytes in the context of rheumatoid arthritis? Identify validated therapeutic targets for rheumatoid arthritis (RA) and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine the overlap between these targets and the set of classical monocyte-activated genes in PINNACLE, as this intersection represents the cell-type–specific RA targets. Calculate the average embedding from this overlapping set and then compute the cosine similarity between the average embedding and each individual target’s embedding. Finally, if one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate, providing a concise, evidence-based rationale for its biological relevance."
"['PANX2', 'TLE3', 'ANKUB1', 'ASXL2', 'YY1AP1']",rheumatoid arthritis,classical monocyte,TLE3,"Among the genes PANX2, TLE3, ANKUB1, ASXL2, and YY1AP1, which exhibits the highest cell-type specificity in classical monocytes and presents the most promising candidate for targeting rheumatoid arthritis?","Among the genes PANX2, TLE3, ANKUB1, ASXL2, and YY1AP1, which exhibits the highest cell-type specificity in classical monocytes and presents the most promising candidate for targeting rheumatoid arthritis? Identify the verified therapeutic targets for rheumatoid arthritis and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the classical monocyte-activated genes in PINNACLE to define the cell-type–specific RA targets. Calculate the average embedding of this set, then compute the cosine similarity between this average and each individual target embedding. If one gene exhibits a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['COL17A1', 'GCNT7', 'SLC25A43', 'ARMC3', 'AHR']",rheumatoid arthritis,classical monocyte,AHR,"Which gene among COL17A1, GCNT7, SLC25A43, ARMC3, and AHR exhibits the highest cell-type specificity in classical monocytes for therapeutic targeting in rheumatoid arthritis?","Which gene among COL17A1, GCNT7, SLC25A43, ARMC3, and AHR exhibits the highest cell-type specificity in classical monocytes for therapeutic targeting in rheumatoid arthritis? Using PINNACLE, identify all verified therapeutic targets for rheumatoid arthritis and obtain their corresponding cell-type-specific embeddings. Next, determine the intersection with the classical monocyte-activated genes from PINNACLE. Compute the average embedding of this overlapping set and calculate the cosine similarity between this average and each individual target’s embedding. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['USP5', 'PSMD13', 'SLC22A18AS', 'ADAM17', 'C12orf50']",rheumatoid arthritis,classical monocyte,ADAM17,"Among the following genes—USP5, PSMD13, SLC22A18AS, ADAM17, and C12orf50—which exhibits the highest cell-type specificity in classical monocytes as a candidate target for rheumatoid arthritis therapy?","Among the following genes—USP5, PSMD13, SLC22A18AS, ADAM17, and C12orf50—which exhibits the highest cell-type specificity in classical monocytes as a candidate target for rheumatoid arthritis therapy? Identify verified therapeutic targets for rheumatoid arthritis and extract their cell type-specific embeddings from PINNACLE. Next, determine which of these targets overlap with classical monocyte-activated genes in PINNACLE to define the subset of cell type-specific targets for rheumatoid arthritis. Compute the average embedding for this overlapping set and calculate the cosine similarity between this average and each individual target. If one gene exhibits a notably higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['UHMK1', 'LAD1', 'CDC42EP3', 'LBHD1', 'LINC01277']",rheumatoid arthritis,classical monocyte,CDC42EP3,"Which gene among UHMK1, LAD1, CDC42EP3, LBHD1, and LINC01277 exhibits the highest specificity in classical monocytes, making it the most promising target for rheumatoid arthritis therapy?","Which gene among UHMK1, LAD1, CDC42EP3, LBHD1, and LINC01277 exhibits the highest specificity in classical monocytes, making it the most promising target for rheumatoid arthritis therapy? Identify the validated therapeutic targets for rheumatoid arthritis and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the classical monocyte-activated genes in PINNACLE to define the cell-type–specific targets. Compute the average embedding for this overlapping set and calculate the cosine similarity between this reference and each individual target. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['KIR2DL4', 'BCDIN3D', 'AIMP1', 'RAB15', 'ZEB2']",rheumatoid arthritis,classical monocyte,ZEB2,"Which gene, selected from KIR2DL4, BCDIN3D, AIMP1, RAB15, and ZEB2, exhibits the highest specificity in classical monocytes and thus represents the most promising target for rheumatoid arthritis therapy?","Which gene, selected from KIR2DL4, BCDIN3D, AIMP1, RAB15, and ZEB2, exhibits the highest specificity in classical monocytes and thus represents the most promising target for rheumatoid arthritis therapy? Identify validated therapeutic targets for rheumatoid arthritis along with their cell-type–specific embeddings from the PINNACLE database. Determine which of these targets overlap with PINNACLE’s classical monocyte-activated genes to define the cell-type–specific targets for rheumatoid arthritis. Next, compute the average embedding of these overlapping genes and calculate the cosine similarity between this reference and each individual target’s embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MTPAP', 'CCDC148', 'SAP130', 'RB1', 'PRMT7']",rheumatoid arthritis,classical monocyte,MTPAP,"Among the genes MTPAP, CCDC148, SAP130, RB1, and PRMT7, which one demonstrates the highest specificity for classical monocytes in the context of rheumatoid arthritis?","Among the genes MTPAP, CCDC148, SAP130, RB1, and PRMT7, which one demonstrates the highest specificity for classical monocytes in the context of rheumatoid arthritis? Identify the validated therapeutic targets for rheumatoid arthritis and extract their cell-type–specific expression embeddings from PINNACLE. Next, determine the intersection between these targets and the classical monocyte-activated genes in PINNACLE, defining this overlap as rheumatoid arthritis cell-type–specific targets. Compute the average embedding vector for this overlapping set and then calculate the cosine similarity between this average and each individual target’s embedding. Finally, if one gene exhibits a markedly higher cosine similarity than the others, designate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['IL1B', 'UBE2V1', 'ALG9', 'CD180', 'SULT1E1']",rheumatoid arthritis,classical monocyte,IL1B,"Among the genes IL1B, UBE2V1, ALG9, CD180, and SULT1E1, which exhibits the highest specificity in classical monocytes and is therefore the most promising target for rheumatoid arthritis treatment?","Among the genes IL1B, UBE2V1, ALG9, CD180, and SULT1E1, which exhibits the highest specificity in classical monocytes and is therefore the most promising target for rheumatoid arthritis treatment? Identify the validated therapeutic targets for rheumatoid arthritis and obtain their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the classical monocyte-activated genes available in PINNACLE to define the cell-type–specific targets for rheumatoid arthritis. Calculate the average embedding of this overlapping set and subsequently compute the cosine similarity between this average and each individual target embedding. If one gene demonstrates a significantly higher similarity than the others, nominate it as the primary candidate and provide a brief, evidence-based explanation of its biological relevance."
"['HLA-DRA', 'NSUN3', 'CLHC1', 'ZNF568', 'LINC00545']",rheumatoid arthritis,classical monocyte,HLA-DRA,"Among HLA-DRA, NSUN3, CLHC1, ZNF568, and LINC00545, which gene exhibits the highest cell-type specificity in classical monocytes as a target for rheumatoid arthritis?","Among HLA-DRA, NSUN3, CLHC1, ZNF568, and LINC00545, which gene exhibits the highest cell-type specificity in classical monocytes as a target for rheumatoid arthritis? Identify the therapeutic targets for rheumatoid arthritis that have been experimentally validated. Retrieve their cell-type–specific embeddings from PINNACLE and identify the overlap with the classical monocyte-activated gene set provided by the same resource. This overlapping gene set represents the cell-type–specific targets for rheumatoid arthritis. Next, compute the average embedding of these overlapping genes as a reference and determine the cosine similarity between this reference and each individual target embedding. If one gene shows a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['TNFRSF14-AS1', 'GOLGA8Q', 'WDR82', 'NFKBIA', 'VPS28']",rheumatoid arthritis,classical monocyte,NFKBIA,"Which gene among TNFRSF14-AS1, GOLGA8Q, WDR82, NFKBIA, and VPS28 shows the highest cell-type specificity in classical monocytes for targeting rheumatoid arthritis?","Which gene among TNFRSF14-AS1, GOLGA8Q, WDR82, NFKBIA, and VPS28 shows the highest cell-type specificity in classical monocytes for targeting rheumatoid arthritis? Retrieve verified therapeutic targets for rheumatoid arthritis and obtain their corresponding cell-type–specific embeddings from the PINNACLE database. Then, identify the overlap between these targets and the classical monocyte-activated genes in PINNACLE. For the overlapping genes, compute the average embedding profile as a reference and calculate the cosine similarity between this reference and each individual gene. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ABCA1', 'HLA-E', 'FEZ2', 'SPOUT1', 'LRP6']",rheumatoid arthritis,classical monocyte,HLA-E,"Which gene among ABCA1, HLA-E, FEZ2, SPOUT1, and LRP6 exhibits the highest classical monocyte-specific expression, making it the most promising candidate for targeted therapy in rheumatoid arthritis?","Which gene among ABCA1, HLA-E, FEZ2, SPOUT1, and LRP6 exhibits the highest classical monocyte-specific expression, making it the most promising candidate for targeted therapy in rheumatoid arthritis? Identify the established therapeutic targets for rheumatoid arthritis and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with PINNACLE’s set of classical monocyte-activated genes, defining this intersection as the cell-type–specific targets. Using these genes, calculate the average embedding as a reference and then compute the cosine similarity between this reference and each individual target’s embedding. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['RAB26', 'LSP1', 'ECHS1', 'RPLP1', 'TTC3-AS1']",rheumatoid arthritis,classical monocyte,RPLP1,"Among the genes RAB26, LSP1, ECHS1, RPLP1, and TTC3-AS1, which one exhibits the highest cell-type specificity in classical monocytes for targeting rheumatoid arthritis?","Among the genes RAB26, LSP1, ECHS1, RPLP1, and TTC3-AS1, which one exhibits the highest cell-type specificity in classical monocytes for targeting rheumatoid arthritis? Identify the verified therapeutic targets for rheumatoid arthritis and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the classical monocyte-activated genes in PINNACLE to define the rheumatoid arthritis cell-type–specific target set. Compute the average embedding for this set and then calculate the cosine similarity between the average reference and each individual target embedding. If one gene exhibits a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['HPS1', 'RBCK1', 'TLE3', 'ZNF569', 'PLAAT2']",rheumatoid arthritis,classical monocyte,TLE3,"Which gene among HPS1, RBCK1, TLE3, ZNF569, or PLAAT2 exhibits the highest cell-type specificity in classical monocytes for therapeutic targeting in rheumatoid arthritis?","Which gene among HPS1, RBCK1, TLE3, ZNF569, or PLAAT2 exhibits the highest cell-type specificity in classical monocytes for therapeutic targeting in rheumatoid arthritis? Identify validated therapeutic targets for rheumatoid arthritis and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with classical monocyte-activated genes in PINNACLE, resulting in a set of cell-type–specific RA targets. Compute the average embedding for this overlapping set, then calculate the cosine similarity between this average and the embedding of each individual target. Finally, if one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['HIF1A', 'URB2', 'RTN4', 'SLC35E4', 'SBF2']",rheumatoid arthritis,classical monocyte,HIF1A,"Which gene among HIF1A, URB2, RTN4, SLC35E4, and SBF2 exhibits the highest cell-type specificity in classical monocytes for the targeted treatment of rheumatoid arthritis?","Which gene among HIF1A, URB2, RTN4, SLC35E4, and SBF2 exhibits the highest cell-type specificity in classical monocytes for the targeted treatment of rheumatoid arthritis? Identify the validated therapeutic targets for rheumatoid arthritis and extract their cell-type–specific embeddings from PINNACLE. Next, determine the overlapping set of these targets with the classical monocyte-activated genes in PINNACLE. Compute the average embedding for this overlapping set as a reference, then calculate the cosine similarity between the reference and each individual target embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['TM9SF3', 'MADD', 'MED13', 'ZEB2', 'ASIC3']",rheumatoid arthritis,classical monocyte,ZEB2,"Which gene among TM9SF3, MADD, MED13, ZEB2, and ASIC3 exhibits the highest cell-type specificity in classical monocytes and represents the best candidate for targeting rheumatoid arthritis?","Which gene among TM9SF3, MADD, MED13, ZEB2, and ASIC3 exhibits the highest cell-type specificity in classical monocytes and represents the best candidate for targeting rheumatoid arthritis? Identify the confirmed therapeutic targets for rheumatoid arthritis using PINNACLE’s cell-type-specific embeddings. Next, determine which of these targets overlap with the set of classical monocyte-activated genes from PINNACLE. Compute the average embedding of the overlapping genes as a reference, then calculate the cosine similarity between this reference and each individual target. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SPCS2', 'RPLP1', 'ZC3H3', 'ANKRD30B', 'PRKAG2']",rheumatoid arthritis,classical monocyte,RPLP1,"Which gene among SPCS2, RPLP1, ZC3H3, ANKRD30B, and PRKAG2 exhibits the highest cell-type specificity in classical monocytes, making it the best candidate for targeted rheumatoid arthritis interventions?","Which gene among SPCS2, RPLP1, ZC3H3, ANKRD30B, and PRKAG2 exhibits the highest cell-type specificity in classical monocytes, making it the best candidate for targeted rheumatoid arthritis interventions? Identify the validated therapeutic targets for rheumatoid arthritis and extract their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the classical monocyte-activated genes in PINNACLE. Using the overlapping set, compute the average embedding as a reference vector, then calculate the cosine similarity between this reference vector and each individual target's embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['TFAP2A', 'ADAM17', 'RHBDD1', 'ZNF837', 'RAB19']",rheumatoid arthritis,classical monocyte,ADAM17,"Which gene among TFAP2A, ADAM17, RHBDD1, ZNF837, and RAB19 exhibits the highest cell-type specificity in classical monocytes for targeting rheumatoid arthritis?","Which gene among TFAP2A, ADAM17, RHBDD1, ZNF837, and RAB19 exhibits the highest cell-type specificity in classical monocytes for targeting rheumatoid arthritis? Identify the validated therapeutic targets for rheumatoid arthritis and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine the overlap with genes activated in classical monocytes within PINNACLE. Calculate the average embedding of this overlapping set, then compute the cosine similarity between this average and each individual target. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['KRTAP5-8', 'GSG1L', 'NLK', 'AHR', 'COL23A1']",rheumatoid arthritis,classical monocyte,AHR,"Which gene among KRTAP5-8, GSG1L, NLK, AHR, and COL23A1 exhibits the highest cell-type specificity in classical monocytes for potential targeting in rheumatoid arthritis?","Which gene among KRTAP5-8, GSG1L, NLK, AHR, and COL23A1 exhibits the highest cell-type specificity in classical monocytes for potential targeting in rheumatoid arthritis? Identify the verified therapeutic targets for rheumatoid arthritis and extract their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the classical monocyte-activated genes cataloged in PINNACLE, yielding a set of cell-type–specific targets. Compute the average embedding of this set as a reference, and then calculate the cosine similarity between the reference and each individual target embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['SLC1A2', 'CDC42EP3', 'ATP6V0A2', 'HIF1AN', 'CELF1']",rheumatoid arthritis,classical monocyte,CDC42EP3,"Which gene among SLC1A2, CDC42EP3, ATP6V0A2, HIF1AN, and CELF1 shows the highest specificity in classical monocytes, indicating its potential as the most promising therapeutic target for rheumatoid arthritis?","Which gene among SLC1A2, CDC42EP3, ATP6V0A2, HIF1AN, and CELF1 shows the highest specificity in classical monocytes, indicating its potential as the most promising therapeutic target for rheumatoid arthritis? Identify validated therapeutic targets for rheumatoid arthritis and extract their cell-type-specific embeddings from PINNACLE. Next, determine which of these targets overlap with known classical monocyte-activated genes in PINNACLE. For the overlapping set, compute the average embedding and then calculate the cosine similarity between this reference and each individual target's embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TRIM4', 'KLHL15', 'ANKRD16', 'ACOT1', 'IRF1']",rheumatoid arthritis,naive b cell,IRF1,"Which gene among TRIM4, KLHL15, ANKRD16, ACOT1, and IRF1 exhibits the highest cell-type specificity in naive B cells for targeting rheumatoid arthritis?","Which gene among TRIM4, KLHL15, ANKRD16, ACOT1, and IRF1 exhibits the highest cell-type specificity in naive B cells for targeting rheumatoid arthritis? Identify the verified therapeutic targets for rheumatoid arthritis within the PINNACLE dataset, specifically those with cell-type–specific embeddings. Next, determine which of these targets overlap with the naive B cell-activated genes in PINNACLE. This overlapping set represents the cell-type–specific targets for rheumatoid arthritis. Compute the average embedding for these genes as a reference, and then calculate the cosine similarity between this reference and the embedding of each individual target gene. If one gene displays a significantly higher similarity compared to the others, nominate it as the top candidate and provide a succinct, evidence-based explanation for its biological relevance."
"['TADA1', 'WDR82', 'MS4A1', 'RASAL2', 'SRGAP1']",rheumatoid arthritis,naive b cell,MS4A1,"Which gene—TADA1, WDR82, MS4A1, RASAL2, or SRGAP1—exhibits the highest specificity for expression in naive B cells, making it the most promising target for rheumatoid arthritis intervention?","Which gene—TADA1, WDR82, MS4A1, RASAL2, or SRGAP1—exhibits the highest specificity for expression in naive B cells, making it the most promising target for rheumatoid arthritis intervention? Identify verified therapeutic targets for rheumatoid arthritis and extract their cell-type–specific embeddings from PINNACLE. Then, determine which of these targets overlap with the naive B cell–activated genes in PINNACLE to define the cell-type–specific targets for rheumatoid arthritis. Compute the average embedding of these overlapping genes and calculate the cosine similarity between this reference profile and each individual gene. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['FOS', 'EPPK1', 'LMCD1-AS1', 'MED6', 'LINC01852']",rheumatoid arthritis,naive b cell,FOS,"Which gene among FOS, EPPK1, LMCD1-AS1, MED6, and LINC01852 exhibits the highest cell-type specificity in naive B cells for rheumatoid arthritis targeting?","Which gene among FOS, EPPK1, LMCD1-AS1, MED6, and LINC01852 exhibits the highest cell-type specificity in naive B cells for rheumatoid arthritis targeting? Using the PINNACLE dataset, identify established therapeutic targets for rheumatoid arthritis and retrieve their cell-type–specific embeddings. Next, determine which of these targets overlap with the gene signature identified in activated naive B cells. Calculate the average embedding of this overlapping set to serve as a reference and compute the cosine similarity between this reference and each individual target’s embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate, and provide a concise, evidence-based rationale for its relevance in rheumatoid arthritis."
"['SRSF11', 'MT-ND3', 'ARL5C', 'DLX4', 'WDR26']",rheumatoid arthritis,naive b cell,MT-ND3,"Which gene—SRSF11, MT-ND3, ARL5C, DLX4, or WDR26—exhibits the highest cell-type-specific expression in naive B cells, making it the most promising target for rheumatoid arthritis therapy?","Which gene—SRSF11, MT-ND3, ARL5C, DLX4, or WDR26—exhibits the highest cell-type-specific expression in naive B cells, making it the most promising target for rheumatoid arthritis therapy? Determine the validated therapeutic targets for rheumatoid arthritis and obtain their cell-type–specific embeddings from the PINNACLE database. Identify which of these targets overlap with naive B cell–activated genes in PINNACLE, defining this overlapping set as the cell-type–specific targets for rheumatoid arthritis. Compute the average embedding of this set and calculate the cosine similarity between this reference vector and each individual target embedding. If one gene demonstrates a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['ATP13A2', 'SPG11', 'AGTPBP1', 'YPEL5', 'GRWD1']",rheumatoid arthritis,naive b cell,YPEL5,"Which gene among ATP13A2, SPG11, AGTPBP1, YPEL5, and GRWD1 exhibits the highest cell-type specificity in naive B cells, thereby serving as the most promising target for rheumatoid arthritis intervention?","Which gene among ATP13A2, SPG11, AGTPBP1, YPEL5, and GRWD1 exhibits the highest cell-type specificity in naive B cells, thereby serving as the most promising target for rheumatoid arthritis intervention? Identify the verified therapeutic targets for rheumatoid arthritis and extract their cell-type–specific embeddings from PINNACLE. Next, determine the intersection between these targets and the set of naive B cell-activated genes in PINNACLE. Compute the average embedding of this overlapping set and calculate the cosine similarity between this reference embedding and each individual target. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NFKBIA', 'XPO5', 'LPGAT1', 'YARS2', 'HDAC8']",rheumatoid arthritis,naive b cell,NFKBIA,"Which gene among NFKBIA, XPO5, LPGAT1, YARS2, and HDAC8 shows the highest specificity in naive B cells for targeting rheumatoid arthritis?","Which gene among NFKBIA, XPO5, LPGAT1, YARS2, and HDAC8 shows the highest specificity in naive B cells for targeting rheumatoid arthritis? Identify the verified therapeutic targets for rheumatoid arthritis and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the naive B cell–activated genes in PINNACLE to define the cell-type–specific targets for rheumatoid arthritis. Calculate the average embedding for this overlapping set and compute the cosine similarity between this average and each individual target. If one gene exhibits a substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['RPS26', 'KCTD1', 'ZNF181', 'MED26', 'TRAV24']",rheumatoid arthritis,naive b cell,RPS26,"Which gene among RPS26, KCTD1, ZNF181, MED26, and TRAV24 exhibits the highest cell-type specificity in naive B cells for targeting rheumatoid arthritis?","Which gene among RPS26, KCTD1, ZNF181, MED26, and TRAV24 exhibits the highest cell-type specificity in naive B cells for targeting rheumatoid arthritis? Identify the confirmed therapeutic targets for rheumatoid arthritis and retrieve their cell-type–specific embeddings from PINNACLE. Next, among the naive B cell–activated genes in PINNACLE, determine which ones overlap with these targets to define the cell-type–specific targets for rheumatoid arthritis. Compute the average embedding for this overlapping set as a reference vector, and calculate the cosine similarity between this reference and each individual target embedding. Finally, if one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate, and provide a concise, evidence-based rationale for its biological relevance."
"['NDFIP2', 'SMARCA1', 'PPP1R12B', 'RPS26', 'FLNA']",rheumatoid arthritis,naive b cell,RPS26,"Among the following genes—NDFIP2, SMARCA1, PPP1R12B, RPS26, and FLNA—which exhibits the highest cell-type specificity in naive B cells and is the most promising target for rheumatoid arthritis?","Among the following genes—NDFIP2, SMARCA1, PPP1R12B, RPS26, and FLNA—which exhibits the highest cell-type specificity in naive B cells and is the most promising target for rheumatoid arthritis? Identify the verified therapeutic targets for rheumatoid arthritis and extract their cell-type–specific embeddings from PINNACLE. Determine the intersection of these targets with the set of naive B cell-activated genes available in PINNACLE. This overlapping subset represents the cell-type–specific targets for rheumatoid arthritis. Next, calculate the average embedding of these genes to serve as a reference vector and compute the cosine similarity between this reference and each target's individual embedding. If one gene exhibits a significantly higher similarity relative to the others, nominate this gene as the top candidate, and provide a concise, evidence-based justification for its biological relevance."
"['SIMC1', 'YPEL5', 'OTOF', 'POMT2', 'LINC01725']",rheumatoid arthritis,naive b cell,YPEL5,"Among the candidate genes SIMC1, YPEL5, OTOF, POMT2, and LINC01725, which one exhibits the highest specificity of expression in naive B cells for potential targeting in rheumatoid arthritis?","Among the candidate genes SIMC1, YPEL5, OTOF, POMT2, and LINC01725, which one exhibits the highest specificity of expression in naive B cells for potential targeting in rheumatoid arthritis? Identify the verified therapeutic targets for rheumatoid arthritis and extract their cell-type–specific embeddings from PINNACLE. Next, determine the intersection between these targets and genes activated in naive B cells. Using the overlapping set, compute the average embedding as a reference point and then calculate the cosine similarity between this reference and each individual gene’s embedding. If one gene exhibits significantly higher similarity relative to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['DNAJC8', 'DLGAP1', 'OGG1', 'FOS', 'EMB']",rheumatoid arthritis,naive b cell,FOS,"Which gene among DNAJC8, DLGAP1, OGG1, FOS, and EMB exhibits the highest cell-type specificity in naive B cells for targeting rheumatoid arthritis?","Which gene among DNAJC8, DLGAP1, OGG1, FOS, and EMB exhibits the highest cell-type specificity in naive B cells for targeting rheumatoid arthritis? Identify the validated therapeutic targets for rheumatoid arthritis and retrieve their cell-type-specific embeddings from PINNACLE. Next, determine which naive B cell–activated genes in PINNACLE overlap with these targets to define the cell-type–specific therapeutic set. Compute the average embedding for this set and then calculate the cosine similarity between this reference and each individual target’s embedding. If one gene exhibits significantly higher similarity than the others, nominate it as the primary candidate and provide a concise, evidence-based rationale for its relevance."
"['TMEM53', 'ATG101', 'FAHD1', 'IRF1', 'CTR9']",rheumatoid arthritis,naive b cell,IRF1,"Among the genes TMEM53, ATG101, FAHD1, IRF1, and CTR9, which one exhibits the highest specificity for naive B cells and thus represents the most promising candidate for targeted rheumatoid arthritis therapy?","Among the genes TMEM53, ATG101, FAHD1, IRF1, and CTR9, which one exhibits the highest specificity for naive B cells and thus represents the most promising candidate for targeted rheumatoid arthritis therapy? Identify the validated therapeutic targets for rheumatoid arthritis and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the naive B cell–activated genes in PINNACLE. Compute the average embedding for this overlapping set and then calculate the cosine similarity between this average and each individual target embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate, providing a concise, evidence-based rationale for its biological relevance."
"['NIBAN2', 'LINC01801', 'RNF157', 'NFKBIA', 'TIMM8B']",rheumatoid arthritis,naive b cell,NFKBIA,"Among the genes NIBAN2, LINC01801, RNF157, NFKBIA, and TIMM8B, which one shows the highest expression specificity in naive B cells relevant to rheumatoid arthritis?","Among the genes NIBAN2, LINC01801, RNF157, NFKBIA, and TIMM8B, which one shows the highest expression specificity in naive B cells relevant to rheumatoid arthritis? Identify validated therapeutic targets for rheumatoid arthritis and obtain their cell-type–specific embeddings from PINNACLE. Then, determine which of these targets overlap with naive B cell activation genes in PINNACLE, defining the set of cell-type–specific targets for rheumatoid arthritis. Compute the average embedding for this overlapping gene set, and calculate the cosine similarity between this average and each individual target’s embedding. Finally, if one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['OR4K13', 'MS4A1', 'CREB3L4', 'TEX10', 'PRKAG1']",rheumatoid arthritis,naive b cell,MS4A1,"Which gene among OR4K13, MS4A1, CREB3L4, TEX10, and PRKAG1 exhibits the highest cell-type specificity in naive B cells for targeting rheumatoid arthritis?","Which gene among OR4K13, MS4A1, CREB3L4, TEX10, and PRKAG1 exhibits the highest cell-type specificity in naive B cells for targeting rheumatoid arthritis? Identify verified therapeutic targets for rheumatoid arthritis and retrieve their cell-type–specific embeddings from PINNACLE. Similarly, obtain the embeddings for naive B cell–activated genes from PINNACLE. Determine the overlapping genes between these two sets to define the cell-type–specific targets for rheumatoid arthritis. Next, calculate the average embedding of this overlap set and compute the cosine similarity between this average and each individual target’s embedding. If one gene exhibits markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['GALNT5', 'SIRT6', 'MT-ND3', 'APOL1', 'GPN1']",rheumatoid arthritis,naive b cell,MT-ND3,"Among the genes GALNT5, SIRT6, MT-ND3, APOL1, and GPN1, which one has the highest cell-type specificity in naive B cells for targeting rheumatoid arthritis?","Among the genes GALNT5, SIRT6, MT-ND3, APOL1, and GPN1, which one has the highest cell-type specificity in naive B cells for targeting rheumatoid arthritis? Identify validated therapeutic targets for rheumatoid arthritis and retrieve their cell-type–specific embeddings from PINNACLE. Next, identify the overlap between these targets and the naive B cell-activated genes in PINNACLE, representing the cell-type–specific RA targets. Compute the average embedding of this overlapping set, then calculate the cosine similarity between this reference and each individual target gene. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['LINC01565', 'IRF1', 'ANKRD36C', 'KRT2', 'ZMYND8']",rheumatoid arthritis,naive b cell,IRF1,"Which gene among LINC01565, IRF1, ANKRD36C, KRT2, and ZMYND8 exhibits the most specific expression in naive B cells in the context of rheumatoid arthritis?","Which gene among LINC01565, IRF1, ANKRD36C, KRT2, and ZMYND8 exhibits the most specific expression in naive B cells in the context of rheumatoid arthritis? Determine the validated therapeutic targets for rheumatoid arthritis and extract their cell-type–specific embeddings from PINNACLE. Next, identify the overlap between these targets and the naive B cell-activated genes in PINNACLE. For the overlapping set, compute the average embedding and calculate the cosine similarity between this reference embedding and each individual target's embedding. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its role in rheumatoid arthritis."
"['LYG1', 'FOS', 'GMNN', 'CRISPLD1', 'RAP1A']",rheumatoid arthritis,naive b cell,FOS,"Among the following genes—LYG1, FOS, GMNN, CRISPLD1, and RAP1A—which exhibits the highest cell-type specificity in naive B cells as a candidate target for rheumatoid arthritis?","Among the following genes—LYG1, FOS, GMNN, CRISPLD1, and RAP1A—which exhibits the highest cell-type specificity in naive B cells as a candidate target for rheumatoid arthritis? Identify validated therapeutic targets for rheumatoid arthritis and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which naive B cell–activated genes in PINNACLE overlap with these targets to define a set of cell-type–specific RA targets. Compute the average embedding for this set, then calculate the cosine similarity between this reference and each target’s embedding. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MT-ND3', 'LINC01140', 'ZNF280D', 'ZNF527', 'BIRC6']",rheumatoid arthritis,naive b cell,MT-ND3,"Which among the genes MT-ND3, LINC01140, ZNF280D, ZNF527, and BIRC6 exhibits the highest cell-type specificity in naive B cells as a target for rheumatoid arthritis?","Which among the genes MT-ND3, LINC01140, ZNF280D, ZNF527, and BIRC6 exhibits the highest cell-type specificity in naive B cells as a target for rheumatoid arthritis? Identify the validated therapeutic targets for rheumatoid arthritis and extract their cell-type–specific embeddings from PINNACLE. Identify the overlap between these targets and the naive B cell activation genes in PINNACLE. For the overlapping genes, compute an average embedding to serve as a reference, then calculate the cosine similarity between this reference and each individual gene embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a clear, evidence-based explanation for its biological relevance."
"['PARD3B', 'RASSF3', 'RNLS', 'RNPEP', 'RPS26']",rheumatoid arthritis,naive b cell,RPS26,"Among the genes PARD3B, RASSF3, RNLS, RNPEP, and RPS26, which exhibits the highest cell-type specificity in naïve B cells, thereby representing the most promising candidate for targeted rheumatoid arthritis therapy?","Among the genes PARD3B, RASSF3, RNLS, RNPEP, and RPS26, which exhibits the highest cell-type specificity in naïve B cells, thereby representing the most promising candidate for targeted rheumatoid arthritis therapy? Identify the validated therapeutic targets for rheumatoid arthritis and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which naive B cell–activated genes in PINNACLE overlap with these targets to define the cell-type–specific targets for rheumatoid arthritis. Compute the average embedding for this overlapping set and calculate the cosine similarity between this reference and each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based explanation for its biological relevance."
"['GXYLT2', 'RAB23', 'STON1', 'NFKBIA', 'STOX1']",rheumatoid arthritis,naive b cell,NFKBIA,"Which gene among GXYLT2, RAB23, STON1, NFKBIA, and STOX1 exhibits the highest cell-type specificity in naive B cells for rheumatoid arthritis targeting?","Which gene among GXYLT2, RAB23, STON1, NFKBIA, and STOX1 exhibits the highest cell-type specificity in naive B cells for rheumatoid arthritis targeting? Identify the verified therapeutic targets for rheumatoid arthritis and retrieve their cell type–specific embeddings from PINNACLE. Then, determine which of these targets overlap with the naive B cell–activated genes in PINNACLE, defining the cell type–specific targets for rheumatoid arthritis. Next, compute the average embedding of this overlapping set as a reference and calculate the cosine similarity between this reference and each individual target. Finally, if one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SLC25A30-AS1', 'FANCA', 'MS4A1', 'SMIM6', 'TMEM129']",rheumatoid arthritis,naive b cell,MS4A1,"Which gene—SLC25A30-AS1, FANCA, MS4A1, SMIM6, or TMEM129—exhibits the highest cell-type specificity in naive B cells for potential targeting in rheumatoid arthritis?","Which gene—SLC25A30-AS1, FANCA, MS4A1, SMIM6, or TMEM129—exhibits the highest cell-type specificity in naive B cells for potential targeting in rheumatoid arthritis? Identify verified therapeutic targets for rheumatoid arthritis and retrieve their cell-type–specific embeddings from PINNACLE. Then, determine which of these targets overlap with the set of naive B cell–activated genes in PINNACLE to define a subset of cell-specific targets. Compute the average embedding of this subset and calculate the cosine similarity between this average and each target. If one gene exhibits a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['RPL21', 'PNPLA4', 'DNASE1L2', 'NMRK1', 'ARMH1']",rheumatoid arthritis,myeloid dendritic cell,RPL21,"Which gene among RPL21, PNPLA4, DNASE1L2, NMRK1, and ARMH1 exhibits the highest cell-type specificity in myeloid dendritic cells for targeting rheumatoid arthritis?","Which gene among RPL21, PNPLA4, DNASE1L2, NMRK1, and ARMH1 exhibits the highest cell-type specificity in myeloid dendritic cells for targeting rheumatoid arthritis? Using the PINNACLE resource, identify the verified therapeutic targets for rheumatoid arthritis and extract their cell-type–specific embeddings. Next, determine which of these targets overlap with the set of genes activated in myeloid dendritic cells to define the cell-type–specific targets for rheumatoid arthritis. Calculate the average embedding of this overlapping set and compute the cosine similarity between this average and the embedding of each individual target. If one gene demonstrates a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SPTSSA', 'WARS1', 'COX4I1', 'EIF4A3', 'C2orf50']",rheumatoid arthritis,myeloid dendritic cell,COX4I1,"Which gene among SPTSSA, WARS1, COX4I1, EIF4A3, and C2orf50 exhibits the highest cell-type specificity in myeloid dendritic cells relevant to rheumatoid arthritis?","Which gene among SPTSSA, WARS1, COX4I1, EIF4A3, and C2orf50 exhibits the highest cell-type specificity in myeloid dendritic cells relevant to rheumatoid arthritis? Identify the verified therapeutic targets for rheumatoid arthritis and extract their cell-type–specific embeddings from PINNACLE. Then, identify which genes among these targets are also present in the myeloid dendritic cell-activated gene set in PINNACLE. Calculate the average embedding of this overlapping set and determine the cosine similarity between this reference and each individual target. Finally, if one gene exhibits a substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological significance in rheumatoid arthritis."
"['NR2C1', 'ATAT1', 'WDR6', 'LRIG2-DT', 'LTB']",rheumatoid arthritis,myeloid dendritic cell,LTB,"Among the genes NR2C1, ATAT1, WDR6, LRIG2-DT, and LTB, which exhibits the highest cell-type specificity in myeloid dendritic cells relevant to targeting rheumatoid arthritis?","Among the genes NR2C1, ATAT1, WDR6, LRIG2-DT, and LTB, which exhibits the highest cell-type specificity in myeloid dendritic cells relevant to targeting rheumatoid arthritis? Identify the validated therapeutic targets for rheumatoid arthritis and obtain their cell-type-specific embeddings from PINNACLE. Next, determine the intersection between these targets and the myeloid dendritic cell–activated genes in PINNACLE. Using the overlapping set, compute the average embedding as a reference and then calculate the cosine similarity between this average embedding and each individual target. Identify the gene with the highest similarity as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['RPL3', 'ARMCX3', 'CPLANE2', 'UQCRHL', 'MAGEE1']",rheumatoid arthritis,myeloid dendritic cell,RPL3,"Among the genes RPL3, ARMCX3, CPLANE2, UQCRHL, and MAGEE1, which one displays the highest cell-type-specific expression in myeloid dendritic cells, thereby serving as the most promising candidate for rheumatoid arthritis targeting?","Among the genes RPL3, ARMCX3, CPLANE2, UQCRHL, and MAGEE1, which one displays the highest cell-type-specific expression in myeloid dendritic cells, thereby serving as the most promising candidate for rheumatoid arthritis targeting? What is the cell-type–specific target gene for rheumatoid arthritis with the highest cosine similarity to the averaged embedding of overlapping myeloid dendritic cell–activated genes from PINNACLE? Specifically, (1) identify all verified therapeutic targets for rheumatoid arthritis; (2) extract their cell-type–specific embeddings from PINNACLE; (3) determine which of these targets overlap with myeloid dendritic cell–activated genes in PINNACLE; (4) compute the average embedding for the overlapping set; and (5) calculate the cosine similarity between this reference embedding and each individual target. If one gene exhibits a notably higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['LINC01630', 'ERCC3', 'CNDP2', 'RPS26', 'C1orf220']",rheumatoid arthritis,myeloid dendritic cell,RPS26,"Which gene among LINC01630, ERCC3, CNDP2, RPS26, and C1orf220 shows the most specific expression in myeloid dendritic cells, indicating its potential as the primary candidate for targeted rheumatoid arthritis therapy?","Which gene among LINC01630, ERCC3, CNDP2, RPS26, and C1orf220 shows the most specific expression in myeloid dendritic cells, indicating its potential as the primary candidate for targeted rheumatoid arthritis therapy? Identify the validated therapeutic targets for rheumatoid arthritis and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with the myeloid dendritic cell-activated genes available in PINNACLE, thereby defining a set of cell-type–specific targets for rheumatoid arthritis. Calculate the average embedding of this set, and then compute the cosine similarity between this average and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['LINC00621', 'HLA-E', 'DMTF1', 'SCAND1', 'RWDD1']",rheumatoid arthritis,myeloid dendritic cell,HLA-E,"Which gene among LINC00621, HLA-E, DMTF1, SCAND1, and RWDD1 exhibits the highest cell-type specificity in myeloid dendritic cells for rheumatoid arthritis targeting?","Which gene among LINC00621, HLA-E, DMTF1, SCAND1, and RWDD1 exhibits the highest cell-type specificity in myeloid dendritic cells for rheumatoid arthritis targeting? Identify the validated therapeutic targets for rheumatoid arthritis and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine which of the genes activated in myeloid dendritic cells in PINNACLE overlap with these targets to define the cell-type–specific targets for rheumatoid arthritis. Compute the average embedding of this overlapping set and calculate the cosine similarity between this reference and the embedding of each target gene. If one gene exhibits a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['SHISA4', 'CCDC175', 'TPRKB', 'KCNK1', 'CD52']",rheumatoid arthritis,myeloid dendritic cell,CD52,"Which gene among SHISA4, CCDC175, TPRKB, KCNK1, and CD52 exhibits the greatest specificity for myeloid dendritic cells, making it the most promising candidate for targeted rheumatoid arthritis therapy?","Which gene among SHISA4, CCDC175, TPRKB, KCNK1, and CD52 exhibits the greatest specificity for myeloid dendritic cells, making it the most promising candidate for targeted rheumatoid arthritis therapy? Identify the verified therapeutic targets for rheumatoid arthritis and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of the myeloid dendritic cell-activated genes in PINNACLE overlap with these targets, thereby defining the cell-type–specific targets for rheumatoid arthritis. Calculate the average embedding of this overlapping set as a reference, then compute the cosine similarity between this reference and each individual target gene's embedding. If one gene shows a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['RBM8A', 'MNS1', 'ACTB', 'ULBP2', 'WASHC2A']",rheumatoid arthritis,myeloid dendritic cell,ACTB,"Among the genes RBM8A, MNS1, ACTB, ULBP2, and WASHC2A, which one exhibits the most specific expression in myeloid dendritic cells, making it the most suitable candidate for targeting rheumatoid arthritis?","Among the genes RBM8A, MNS1, ACTB, ULBP2, and WASHC2A, which one exhibits the most specific expression in myeloid dendritic cells, making it the most suitable candidate for targeting rheumatoid arthritis? Identify the validated therapeutic targets for rheumatoid arthritis and retrieve their cell-type–specific embeddings from PINNACLE. Next, from these targets, select the genes that are activated in myeloid dendritic cells according to PINNACLE data—these represent the cell-type–specific targets for rheumatoid arthritis. Compute the average embedding of this overlapping set, then determine the cosine similarity between this reference and the individual target embeddings. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['FAM182B', 'MAP7', 'LRRC57', 'RPLP1', 'STRN']",rheumatoid arthritis,myeloid dendritic cell,RPLP1,"Which gene among FAM182B, MAP7, LRRC57, RPLP1, and STRN exhibits the highest specificity in myeloid dendritic cells, thereby representing the most promising target for rheumatoid arthritis therapy?","Which gene among FAM182B, MAP7, LRRC57, RPLP1, and STRN exhibits the highest specificity in myeloid dendritic cells, thereby representing the most promising target for rheumatoid arthritis therapy? Identify therapeutically validated targets for rheumatoid arthritis and obtain their cell-type–specific embeddings from PINNACLE. Next, identify which genes among those activated in myeloid dendritic cells overlap with these targets. Compute the average embedding for this overlapping set and calculate the cosine similarity between this average and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, select it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ASB3', 'TRAV24', 'KAT5', 'ARTN', 'HLA-E']",rheumatoid arthritis,myeloid dendritic cell,HLA-E,"Among the genes ASB3, TRAV24, KAT5, ARTN, and HLA-E, which one shows the highest specificity for myeloid dendritic cells, making it the most promising target for rheumatoid arthritis therapy?","Among the genes ASB3, TRAV24, KAT5, ARTN, and HLA-E, which one shows the highest specificity for myeloid dendritic cells, making it the most promising target for rheumatoid arthritis therapy? Identify the verified therapeutic targets for rheumatoid arthritis and extract their cell-type–specific embeddings from PINNACLE. Then, determine which of these targets overlap with genes activated in myeloid dendritic cells according to PINNACLE. Next, compute the average embedding of the overlapping set and calculate the cosine similarity between this reference and each individual target. If one gene exhibits notably higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['RPL21', 'OBSCN-AS1', 'CLASP2', 'RANBP2', 'RAB40A']",rheumatoid arthritis,myeloid dendritic cell,RPL21,"Which gene among RPL21, OBSCN-AS1, CLASP2, RANBP2, and RAB40A exhibits the highest specificity in myeloid dendritic cells, thereby representing the most promising candidate for rheumatoid arthritis targeting?","Which gene among RPL21, OBSCN-AS1, CLASP2, RANBP2, and RAB40A exhibits the highest specificity in myeloid dendritic cells, thereby representing the most promising candidate for rheumatoid arthritis targeting? Identify the verified therapeutic targets for rheumatoid arthritis and retrieve their corresponding cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the genes activated in myeloid dendritic cells in PINNACLE. Calculate the average embedding for the overlapping gene set, then assess the cosine similarity between this reference embedding and each individual target embedding. Finally, if a single gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['COX4I1', 'SAMD12-AS1', 'RHOF', 'LINC02362', 'IATPR']",rheumatoid arthritis,myeloid dendritic cell,COX4I1,"Among the genes COX4I1, SAMD12-AS1, RHOF, LINC02362, and IATPR, which one exhibits the highest cell-type specificity within myeloid dendritic cells for targeted intervention in rheumatoid arthritis?","Among the genes COX4I1, SAMD12-AS1, RHOF, LINC02362, and IATPR, which one exhibits the highest cell-type specificity within myeloid dendritic cells for targeted intervention in rheumatoid arthritis? Identify the validated therapeutic targets for rheumatoid arthritis and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which genes activated in myeloid dendritic cells overlap with these targets. Compute the average embedding of this overlapping set and calculate the cosine similarity between this reference and the embedding of each individual gene target. If one gene exhibits a substantially higher similarity than the others, nominate it as the top candidate for rheumatoid arthritis intervention, and provide a concise, evidence-based rationale for its biological significance."
"['LTB', 'PLEKHA3', 'TFR2', 'DNMBP-AS1', 'DCTN1']",rheumatoid arthritis,myeloid dendritic cell,LTB,"Among the genes LTB, PLEKHA3, TFR2, DNMBP-AS1, and DCTN1, which one exhibits the highest cell-type specificity in myeloid dendritic cells as a potential target for rheumatoid arthritis?","Among the genes LTB, PLEKHA3, TFR2, DNMBP-AS1, and DCTN1, which one exhibits the highest cell-type specificity in myeloid dendritic cells as a potential target for rheumatoid arthritis? Identify the validated therapeutic targets for rheumatoid arthritis and obtain their cell-type-specific embeddings from PINNACLE. Next, determine the intersection of these targets with genes activated in myeloid dendritic cells within PINNACLE. Calculate the average embedding for this overlapping set, then compute the cosine similarity between this average and each individual target embedding. If one gene exhibits a significantly higher similarity compared to the others, nominate it as the top candidate and provide a brief, evidence-based rationale for its biological relevance."
"['SNF8', 'AOC1', 'FAM184B', 'ACTB', 'NUMBL']",rheumatoid arthritis,myeloid dendritic cell,ACTB,"Which gene among SNF8, AOC1, FAM184B, ACTB, and NUMBL exhibits the highest myeloid dendritic cell specificity for targeting rheumatoid arthritis?","Which gene among SNF8, AOC1, FAM184B, ACTB, and NUMBL exhibits the highest myeloid dendritic cell specificity for targeting rheumatoid arthritis? Identify the clinically validated therapeutic targets for rheumatoid arthritis and retrieve their cell-type–specific embeddings from PINNACLE. Then, determine which genes activated in myeloid dendritic cells in PINNACLE overlap with these targets to define cell-type–specific targets for rheumatoid arthritis. Compute the average embedding for this overlapping gene set and calculate the cosine similarity between this reference and each individual target. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CAVIN1', 'CD52', 'ATXN2-AS', 'KIF9', 'NECTIN4']",rheumatoid arthritis,myeloid dendritic cell,CD52,"Among the genes CAVIN1, CD52, ATXN2-AS, KIF9, and NECTIN4, which exhibits the highest cell-type specificity in myeloid dendritic cells for targeting rheumatoid arthritis?","Among the genes CAVIN1, CD52, ATXN2-AS, KIF9, and NECTIN4, which exhibits the highest cell-type specificity in myeloid dendritic cells for targeting rheumatoid arthritis? Identify the RA therapeutic targets validated in previous studies and extract their corresponding cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with the myeloid dendritic cell-activated genes available in PINNACLE, defining this intersection as the cell-type–specific RA targets. Compute the average embedding for this group, then calculate the cosine similarity between this reference vector and each individual target’s embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['COCH', 'HSPA4L', 'RPLP1', 'C6orf132', 'PTPRE']",rheumatoid arthritis,myeloid dendritic cell,RPLP1,"Among the genes COCH, HSPA4L, RPLP1, C6orf132, and PTPRE, which one shows the highest specificity for myeloid dendritic cells, making it the most promising target for rheumatoid arthritis therapy?","Among the genes COCH, HSPA4L, RPLP1, C6orf132, and PTPRE, which one shows the highest specificity for myeloid dendritic cells, making it the most promising target for rheumatoid arthritis therapy? Identify the validated therapeutic targets for rheumatoid arthritis and extract their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the myeloid dendritic cell–activated genes in PINNACLE to obtain the cell-type–specific targets for rheumatoid arthritis. Compute the average embedding for this overlapping set, then calculate the cosine similarity between the average embedding and each individual gene's embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['FZD3', 'CHMP6', 'RPS26', 'CMTM3', 'UTY']",rheumatoid arthritis,myeloid dendritic cell,RPS26,"Which gene among FZD3, CHMP6, RPS26, CMTM3, and UTY demonstrates the highest specificity in myeloid dendritic cells for targeting rheumatoid arthritis?","Which gene among FZD3, CHMP6, RPS26, CMTM3, and UTY demonstrates the highest specificity in myeloid dendritic cells for targeting rheumatoid arthritis? Identify validated rheumatoid arthritis therapeutic targets by retrieving their cell-type specific embeddings from PINNACLE. Next, determine which myeloid dendritic cell-activated genes in PINNACLE overlap with these targets to define a set of cell-type specific RA targets. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between this reference and the embedding of each individual target. If one gene exhibits a distinctly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance in rheumatoid arthritis."
"['DCP2', 'SWSAP1', 'ARHGAP8', 'RPL3', 'APLP2']",rheumatoid arthritis,myeloid dendritic cell,RPL3,"Among the genes DCP2, SWSAP1, ARHGAP8, RPL3, and APLP2, which one exhibits the highest cell-type specificity in myeloid dendritic cells, making it the most promising target for rheumatoid arthritis therapy?","Among the genes DCP2, SWSAP1, ARHGAP8, RPL3, and APLP2, which one exhibits the highest cell-type specificity in myeloid dendritic cells, making it the most promising target for rheumatoid arthritis therapy? Identify all validated therapeutic targets for rheumatoid arthritis and extract their corresponding cell-type–specific embeddings from the PINNACLE database. Next, determine which targets overlap with genes activated in myeloid dendritic cells as recorded in PINNACLE; these overlapping genes represent the cell-type–specific RA targets. Compute the average embedding for this overlapping set, then calculate the cosine similarity between the average embedding and each individual target’s embedding. If one gene exhibits a significantly higher cosine similarity compared to the others, nominate that gene as the top candidate and provide a concise, evidence-based explanation for its biological relevance in RA."
"['SERTAD3', 'SARNP', 'VPS50', 'CLINT1', 'CD52']",rheumatoid arthritis,myeloid dendritic cell,CD52,"Among the genes SERTAD3, SARNP, VPS50, CLINT1, and CD52, which exhibits the highest cell-type specificity in myeloid dendritic cells for targeting rheumatoid arthritis?","Among the genes SERTAD3, SARNP, VPS50, CLINT1, and CD52, which exhibits the highest cell-type specificity in myeloid dendritic cells for targeting rheumatoid arthritis? Determine the validated therapeutic targets for rheumatoid arthritis and retrieve their cell-type–specific embeddings from the PINNACLE database. From the set of myeloid dendritic cell-activated genes in PINNACLE, identify those that overlap with the therapeutic targets to obtain a subset of cell-type–specific targets. Compute the average embedding for this subset and calculate the cosine similarity between this average and the embedding of each individual target. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['WDR55', 'NTMT1', 'RPLP1', 'NPAS3', 'SPON1']",rheumatoid arthritis,myeloid dendritic cell,RPLP1,"Among the genes WDR55, NTMT1, RPLP1, NPAS3, and SPON1, which one exhibits the highest cell-type specificity in myeloid dendritic cells as a potential target for rheumatoid arthritis therapy?","Among the genes WDR55, NTMT1, RPLP1, NPAS3, and SPON1, which one exhibits the highest cell-type specificity in myeloid dendritic cells as a potential target for rheumatoid arthritis therapy? Given the verified therapeutic targets for rheumatoid arthritis and their cell-type–specific embeddings from PINNACLE, identify the subset that overlaps with myeloid dendritic cell-activated genes in PINNACLE. Calculate the average embedding of this overlapping set and determine the cosine similarity between this reference and each individual target gene. If one gene exhibits a significantly higher similarity than the others, nominate it as the prime candidate and provide a concise, evidence-based rationale for its biological relevance."
"['C4orf19', 'HTR2A', 'NKAP', 'HLA-C', 'NPEPL1']",rheumatoid arthritis,naive thymus derived cd8 positive alpha beta t cell,HLA-C,"Which gene among C4orf19, HTR2A, NKAP, HLA-C, and NPEPL1 exhibits the highest cell-type specificity in naive thymus-derived CD8+ alpha-beta T cells, making it the most promising target for rheumatoid arthritis?","Which gene among C4orf19, HTR2A, NKAP, HLA-C, and NPEPL1 exhibits the highest cell-type specificity in naive thymus-derived CD8+ alpha-beta T cells, making it the most promising target for rheumatoid arthritis? Identify the validated therapeutic targets for rheumatoid arthritis and retrieve their cell-type–specific embeddings from the PINNACLE dataset. Next, identify the overlap between these targets and the activated genes from naive thymus–derived CD8+ alpha-beta T cells in PINNACLE, defining this overlap as the cell-type–specific targets for rheumatoid arthritis. Calculate the average embedding for these overlapping genes, then measure the cosine similarity between this reference embedding and each individual gene’s embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['FOS', 'RBP7', 'CNN3-DT', 'IFT88', 'LINC02422']",rheumatoid arthritis,naive thymus derived cd8 positive alpha beta t cell,FOS,"Which gene among FOS, RBP7, CNN3-DT, IFT88, and LINC02422 exhibits the highest cell-type specificity in naive thymus-derived CD8+ αβ T cells for targeting rheumatoid arthritis?","Which gene among FOS, RBP7, CNN3-DT, IFT88, and LINC02422 exhibits the highest cell-type specificity in naive thymus-derived CD8+ αβ T cells for targeting rheumatoid arthritis? Identify all verified therapeutic targets for rheumatoid arthritis and retrieve their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which of these targets overlap with the naive thymus-derived CD8+ αβ T cell-activated genes provided in PINNACLE. Compute the average embedding for the overlapping set and calculate the cosine similarity between this average and each individual target’s embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ZNF674', 'RUVBL1', 'MT-ND3', 'INTS12', 'ATP6V0E1']",rheumatoid arthritis,naive thymus derived cd8 positive alpha beta t cell,MT-ND3,"Which gene among ZNF674, RUVBL1, MT-ND3, INTS12, and ATP6V0E1 exhibits the highest cell-type-specific expression in naive thymus-derived CD8+ αβ T cells, making it the most promising candidate for targeted rheumatoid arthritis interventions?","Which gene among ZNF674, RUVBL1, MT-ND3, INTS12, and ATP6V0E1 exhibits the highest cell-type-specific expression in naive thymus-derived CD8+ αβ T cells, making it the most promising candidate for targeted rheumatoid arthritis interventions? Identify the validated therapeutic targets for rheumatoid arthritis and extract their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the activated genes identified in naive thymus-derived CD8+ alpha-beta T cells in PINNACLE to define the cell-type–specific targets for rheumatoid arthritis. Compute the average embedding for this overlapping set and calculate the cosine similarity between the average and each individual target embedding. If one gene exhibits a notably higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MSS51', 'MT-ND6', 'ZNF789', 'SMAD5-AS1', 'ADGRF5']",rheumatoid arthritis,naive thymus derived cd8 positive alpha beta t cell,MT-ND6,"Among the genes MSS51, MT-ND6, ZNF789, SMAD5-AS1, and ADGRF5, which exhibits the highest cell-type specificity in naive thymus-derived CD8+ αβ T cells for targeted rheumatoid arthritis interventions?","Among the genes MSS51, MT-ND6, ZNF789, SMAD5-AS1, and ADGRF5, which exhibits the highest cell-type specificity in naive thymus-derived CD8+ αβ T cells for targeted rheumatoid arthritis interventions? Identify the verified therapeutic targets for rheumatoid arthritis and obtain their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the genes activated in naive thymus–derived CD8+ αβ T cells in PINNACLE to define the cell-type–specific targets for rheumatoid arthritis. Compute the average embedding of this overlapping set and then calculate the cosine similarity between this average and the embedding of each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['KLHL8', 'DDX6', 'ZNF783', 'RYR1', 'EDARADD']",rheumatoid arthritis,naive thymus derived cd8 positive alpha beta t cell,DDX6,"Which gene among KLHL8, DDX6, ZNF783, RYR1, and EDARADD exhibits the highest cell-type specificity in naive thymus-derived CD8+ αβ T cells for potential targeting in rheumatoid arthritis?","Which gene among KLHL8, DDX6, ZNF783, RYR1, and EDARADD exhibits the highest cell-type specificity in naive thymus-derived CD8+ αβ T cells for potential targeting in rheumatoid arthritis? Identify validated therapeutic targets for rheumatoid arthritis and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which naive thymus–derived CD8⁺ αβ T-cell activated genes in PINNACLE overlap with these targets, thereby defining a set of cell-type–specific RA targets. Compute the average embedding for these overlapping genes and then calculate the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CBX6', 'H2AC21', 'ARL8A', 'RABEPK', 'NFKBIA']",rheumatoid arthritis,naive thymus derived cd8 positive alpha beta t cell,NFKBIA,"Among CBX6, H2AC21, ARL8A, RABEPK, and NFKBIA, which gene exhibits the highest cell-type specificity in naive thymus-derived CD8+ αβ T cells and therefore represents the best candidate for targeting rheumatoid arthritis?","Among CBX6, H2AC21, ARL8A, RABEPK, and NFKBIA, which gene exhibits the highest cell-type specificity in naive thymus-derived CD8+ αβ T cells and therefore represents the best candidate for targeting rheumatoid arthritis? Identify validated therapeutic targets for rheumatoid arthritis and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which naive thymus–derived CD8+ αβ T cell–activated genes in PINNACLE overlap with these targets. Calculate the average embedding of the overlapping gene set as a reference, then compute the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ANG', 'TAF9B', 'CD52', 'ZNF714', 'RFNG']",rheumatoid arthritis,naive thymus derived cd8 positive alpha beta t cell,CD52,"Which gene among ANG, TAF9B, CD52, ZNF714, and RFNG exhibits the highest cell-type specificity in naïve thymus-derived CD8+ αβ T cells, making it the most promising candidate for targeting rheumatoid arthritis?","Which gene among ANG, TAF9B, CD52, ZNF714, and RFNG exhibits the highest cell-type specificity in naïve thymus-derived CD8+ αβ T cells, making it the most promising candidate for targeting rheumatoid arthritis? Identify the experimentally validated therapeutic targets for rheumatoid arthritis and extract their cell-type–specific embeddings from the PINNACLE dataset. Next, determine the overlap between these targets and genes activated in naive, thymus-derived CD8+ alpha–beta T cells within PINNACLE to define the cell-type–specific targets for rheumatoid arthritis. Calculate the average embedding for this overlapping set as a reference, then compute the cosine similarity between this reference vector and each individual target’s embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['RPL21', 'RGS18', 'PCGF3', 'GDI2', 'ZNF599']",rheumatoid arthritis,naive thymus derived cd8 positive alpha beta t cell,RPL21,"Which gene among RPL21, RGS18, PCGF3, GDI2, and ZNF599 exhibits the highest cell-type specificity in naive thymus-derived CD8⁺ αβ T cells, making it the most appropriate candidate for targeting rheumatoid arthritis?","Which gene among RPL21, RGS18, PCGF3, GDI2, and ZNF599 exhibits the highest cell-type specificity in naive thymus-derived CD8⁺ αβ T cells, making it the most appropriate candidate for targeting rheumatoid arthritis? Identify the validated therapeutic targets for rheumatoid arthritis and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the set of naive thymus-derived CD8+ αβ T cell-activated genes available in PINNACLE. Compute the average embedding for this overlapping gene set to serve as a reference, and then calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a significantly higher cosine similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['H3C11', 'FBXW12', 'LTB', 'C2orf69', 'CACNA2D2']",rheumatoid arthritis,naive thymus derived cd8 positive alpha beta t cell,LTB,"Among the genes H3C11, FBXW12, LTB, C2orf69, and CACNA2D2, which demonstrates the highest cell-type-specific expression in naïve thymus-derived CD8+ αβ T cells and is the most promising candidate for targeting rheumatoid arthritis?","Among the genes H3C11, FBXW12, LTB, C2orf69, and CACNA2D2, which demonstrates the highest cell-type-specific expression in naïve thymus-derived CD8+ αβ T cells and is the most promising candidate for targeting rheumatoid arthritis? Identify the validated therapeutic targets for rheumatoid arthritis and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine the overlap between these targets and the genes activated in naive thymus-derived CD8+ αβ T cells in PINNACLE. Average the embeddings of the overlapping gene set to create a reference embedding, then compute the cosine similarity between this reference and the embeddings of each target. If one gene displays a considerably higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['RPL3', 'ANP32E', 'LINC01044', 'ZNF470', 'CADM4']",rheumatoid arthritis,naive thymus derived cd8 positive alpha beta t cell,RPL3,"Which gene among RPL3, ANP32E, LINC01044, ZNF470, and CADM4 exhibits the greatest cell-type specificity in naïve thymus-derived CD8+ αβ T cells, making it the most promising candidate for targeting rheumatoid arthritis?","Which gene among RPL3, ANP32E, LINC01044, ZNF470, and CADM4 exhibits the greatest cell-type specificity in naïve thymus-derived CD8+ αβ T cells, making it the most promising candidate for targeting rheumatoid arthritis? Identify validated therapeutic targets for rheumatoid arthritis and obtain their cell-type specific embeddings from PINNACLE. Next, determine which of these targets overlap with genes activated in naive thymus-derived CD8+ αβ T cells from PINNACLE. Using this overlapping set as the cell-type specific rheumatoid arthritis targets, compute their average embedding to serve as a reference, then calculate the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CSDE1', 'PRRT3', 'ACTB', 'NANOGNB', 'VCPIP1']",rheumatoid arthritis,naive thymus derived cd8 positive alpha beta t cell,ACTB,"Which of the following genes—CSDE1, PRRT3, ACTB, NANOGNB, or VCPIP1—displays the highest specificity for naive thymus-derived CD8+ alpha–beta T cells, thereby representing the most promising target for rheumatoid arthritis studies?","Which of the following genes—CSDE1, PRRT3, ACTB, NANOGNB, or VCPIP1—displays the highest specificity for naive thymus-derived CD8+ alpha–beta T cells, thereby representing the most promising target for rheumatoid arthritis studies? Using the PINNACLE database, identify validated therapeutic targets for rheumatoid arthritis and retrieve their cell-type–specific embeddings. Next, determine the overlap between these targets and the genes activated in naive thymus-derived CD8+ αβ T cells, thereby defining a subset of cell-type–specific targets. Compute the average embedding for this overlapping set and calculate the cosine similarity between this average and each individual target embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['RLN1', 'S100A10', 'ZNF746', 'KLHL2', 'TRIP10']",rheumatoid arthritis,naive thymus derived cd8 positive alpha beta t cell,S100A10,"Which gene among RLN1, S100A10, ZNF746, KLHL2, and TRIP10 exhibits the highest cell-type specificity in naïve thymus‐derived CD8+ αβ T cells, making it the most promising candidate for therapeutic targeting in rheumatoid arthritis?","Which gene among RLN1, S100A10, ZNF746, KLHL2, and TRIP10 exhibits the highest cell-type specificity in naïve thymus‐derived CD8+ αβ T cells, making it the most promising candidate for therapeutic targeting in rheumatoid arthritis? Retrieve the verified therapeutic targets for rheumatoid arthritis from PINNACLE and obtain their cell-type–specific embeddings. Next, identify which of these targets overlap with the embeddings corresponding to naive thymus–derived CD8+ alpha-beta T cell–activated genes in PINNACLE. Calculate the average embedding for this overlapping set and determine the cosine similarity between this average and each individual target’s embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TMEM115', 'LARP4', 'KLHDC8B', 'PRKRA', 'RPS26']",rheumatoid arthritis,naive thymus derived cd8 positive alpha beta t cell,RPS26,"Among the genes TMEM115, LARP4, KLHDC8B, PRKRA, and RPS26, which one exhibits the highest cell-type specificity in naïve thymus-derived CD8⁺ αβ T cells, making it the most promising candidate for targeting in rheumatoid arthritis?","Among the genes TMEM115, LARP4, KLHDC8B, PRKRA, and RPS26, which one exhibits the highest cell-type specificity in naïve thymus-derived CD8⁺ αβ T cells, making it the most promising candidate for targeting in rheumatoid arthritis? Identify the validated therapeutic targets for rheumatoid arthritis and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with the gene set associated with naive thymus-derived CD8+ αβ T cell activation from PINNACLE. Compute the average embedding for this overlapping set as a reference, and then calculate the cosine similarity between the reference and each individual target embedding. If one gene exhibits a significantly higher cosine similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['JADE1', 'RPLP1', 'LRRC56', 'DHDH', 'SH3D21']",rheumatoid arthritis,naive thymus derived cd8 positive alpha beta t cell,RPLP1,"Among the genes JADE1, RPLP1, LRRC56, DHDH, and SH3D21, which one exhibits the highest cell-type-specific expression in naive thymus-derived CD8+ αβ T cells, making it the most promising candidate for targeted rheumatoid arthritis therapy?","Among the genes JADE1, RPLP1, LRRC56, DHDH, and SH3D21, which one exhibits the highest cell-type-specific expression in naive thymus-derived CD8+ αβ T cells, making it the most promising candidate for targeted rheumatoid arthritis therapy? Identify and validate therapeutic targets for rheumatoid arthritis by retrieving their cell-type-specific embeddings from PINNACLE. Next, determine the overlap between these targets and the naive thymus-derived CD8+ αβ T cell-activated genes, designating the overlapping genes as RA-specific targets. Compute the average embedding for these targets as a reference, then calculate the cosine similarity between this reference and each individual target's embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SRA1', 'DNAJC5', 'NFKBIA', 'RAN', 'ZNF597']",rheumatoid arthritis,naive thymus derived cd8 positive alpha beta t cell,NFKBIA,"Among the genes SRA1, DNAJC5, NFKBIA, RAN, and ZNF597, which one exhibits the highest cell-type specificity in naive thymus-derived CD8+ αβ T cells as a candidate for targeted intervention in rheumatoid arthritis?","Among the genes SRA1, DNAJC5, NFKBIA, RAN, and ZNF597, which one exhibits the highest cell-type specificity in naive thymus-derived CD8+ αβ T cells as a candidate for targeted intervention in rheumatoid arthritis? Using PINNACLE, identify and extract the cell-type-specific embeddings for validated therapeutic targets of rheumatoid arthritis. Next, determine which of these targets overlap with genes activated in naive thymus-derived CD8+ αβ T cells. For this overlapping gene set, compute the average embedding vector and then calculate the cosine similarity of each gene's embedding to the reference vector. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['LTB', 'PHAX', 'ARFIP1', 'PECR', 'ZBED1_ENSG00000214717']",rheumatoid arthritis,naive thymus derived cd8 positive alpha beta t cell,LTB,"Which gene among LTB, PHAX, ARFIP1, PECR, and ZBED1_ENSG00000214717 exhibits the highest cell-type specificity in naive thymus-derived CD8+ αβ T cells, making it the most promising target for rheumatoid arthritis interventions?","Which gene among LTB, PHAX, ARFIP1, PECR, and ZBED1_ENSG00000214717 exhibits the highest cell-type specificity in naive thymus-derived CD8+ αβ T cells, making it the most promising target for rheumatoid arthritis interventions? Identify and verify the therapeutic targets for rheumatoid arthritis, then extract their cell-type–specific embeddings from PINNACLE. Next, identify the intersection between these targets and the genes activated in naive thymus-derived CD8+ alpha-beta T cells in PINNACLE, as these overlapping genes represent the cell-type–specific targets. Compute the average embedding for this set, and determine the cosine similarity between the average and each individual target’s embedding. If one gene exhibits substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based justification for its biological relevance."
"['ARL4C', 'SLC7A6OS', 'LZIC', 'MT-ND3', 'PRR23C']",rheumatoid arthritis,naive thymus derived cd8 positive alpha beta t cell,MT-ND3,"Among the genes ARL4C, SLC7A6OS, LZIC, MT-ND3, and PRR23C, which one exhibits the highest cell-type specificity in naive thymus-derived CD8+ alpha-beta T cells for targeted rheumatoid arthritis interventions?","Among the genes ARL4C, SLC7A6OS, LZIC, MT-ND3, and PRR23C, which one exhibits the highest cell-type specificity in naive thymus-derived CD8+ alpha-beta T cells for targeted rheumatoid arthritis interventions? Identify the validated therapeutic targets for rheumatoid arthritis and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, compare these targets with the naive thymus–derived CD8+ αβ T-cell activation genes in PINNACLE to determine the overlapping set, which represents the cell-type–specific therapeutic targets. Compute the average embedding of these overlapping genes and calculate the cosine similarity between this reference embedding and each individual target's embedding. If one gene exhibits a markedly higher similarity than all others, nominate it as the top candidate and provide a succinct, evidence-based rationale for its biological relevance."
"['CAPNS2', 'ALDH3A2', 'TXLNB', 'RPS26', 'CDCA2']",rheumatoid arthritis,naive thymus derived cd8 positive alpha beta t cell,RPS26,"Among the genes CAPNS2, ALDH3A2, TXLNB, RPS26, and CDCA2, which exhibits the highest specificity in naive, thymus-derived CD8+ alpha-beta T cells for potential targeting in rheumatoid arthritis?","Among the genes CAPNS2, ALDH3A2, TXLNB, RPS26, and CDCA2, which exhibits the highest specificity in naive, thymus-derived CD8+ alpha-beta T cells for potential targeting in rheumatoid arthritis? Identify the validated rheumatoid arthritis therapeutic targets along with their cell-type–specific embeddings from the PINNACLE database. Next, determine the intersection between these targets and the activated, naive thymus–derived CD8+ alpha beta T cell genes in PINNACLE. Compute the average embedding of this overlapping gene set and then calculate the cosine similarity between this average embedding and those of the individual targets. If one gene displays a significantly higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based rationale for its biological relevance."
"['C1orf87', 'MORF4L2', 'CHODL', 'TBCD', 'DDX6']",rheumatoid arthritis,naive thymus derived cd8 positive alpha beta t cell,DDX6,"Which gene—C1orf87, MORF4L2, CHODL, TBCD, or DDX6—exhibits the highest cell-type specificity in naive thymus-derived CD8+ alpha-beta T cells for potential targeting in rheumatoid arthritis?","Which gene—C1orf87, MORF4L2, CHODL, TBCD, or DDX6—exhibits the highest cell-type specificity in naive thymus-derived CD8+ alpha-beta T cells for potential targeting in rheumatoid arthritis? Identify verified therapeutic targets for rheumatoid arthritis and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with naive thymus-derived CD8 positive alpha–beta T cell-activated genes available in PINNACLE. For the resulting set of overlapping genes, compute the average embedding as a reference vector, then evaluate the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ST3GAL6', 'MT-ND6', 'SCAF11', 'GNAL', 'SLX4IP']",rheumatoid arthritis,naive thymus derived cd8 positive alpha beta t cell,MT-ND6,"Which gene among ST3GAL6, MT-ND6, SCAF11, GNAL, and SLX4IP exhibits the highest cell-type specificity in naive thymus-derived CD8+ αβ T cells, making it the most promising target for rheumatoid arthritis?","Which gene among ST3GAL6, MT-ND6, SCAF11, GNAL, and SLX4IP exhibits the highest cell-type specificity in naive thymus-derived CD8+ αβ T cells, making it the most promising target for rheumatoid arthritis? Identify the validated therapeutic targets for rheumatoid arthritis and obtain their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the genes associated with naive thymus-derived CD8+ alpha-beta T cell activation in PINNACLE; this overlapping set represents the cell-type–specific targets for the disease. Compute the average embedding for this set as a reference, and calculate the cosine similarity between the reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['PTPN7', 'LINC00940', 'RPL21', 'RGS20', 'KHDC1L']",rheumatoid arthritis,naive thymus derived cd4 positive alpha beta t cell,RPL21,"Among the genes PTPN7, LINC00940, RPL21, RGS20, and KHDC1L, which one exhibits the highest cell-type specificity in naive thymus-derived CD4+ αβ T cells and emerges as the most promising candidate for targeting rheumatoid arthritis?","Among the genes PTPN7, LINC00940, RPL21, RGS20, and KHDC1L, which one exhibits the highest cell-type specificity in naive thymus-derived CD4+ αβ T cells and emerges as the most promising candidate for targeting rheumatoid arthritis? Identify validated therapeutic targets for rheumatoid arthritis and obtain their cell-type–specific embeddings from the PINNACLE platform. Next, determine which targets overlap with genes activated in naive thymus‐derived CD4+ alpha-beta T cells as documented in PINNACLE. Compute the average embedding for this overlapping gene set, then calculate the cosine similarity between this average and each individual target’s embedding. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ZNF706', 'HBG2', 'KIAA2012', 'ACTB', 'SPPL3']",rheumatoid arthritis,naive thymus derived cd4 positive alpha beta t cell,ACTB,"Among the genes ZNF706, HBG2, KIAA2012, ACTB, and SPPL3, which one exhibits the highest cell-type specificity in naive thymus-derived CD4+ αβ T cells for targeted rheumatoid arthritis therapies?","Among the genes ZNF706, HBG2, KIAA2012, ACTB, and SPPL3, which one exhibits the highest cell-type specificity in naive thymus-derived CD4+ αβ T cells for targeted rheumatoid arthritis therapies? Identify the validated therapeutic targets for rheumatoid arthritis and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the set of naive thymus–derived CD4+ αβ T cell activation genes in PINNACLE. Compute the average embedding for the overlapping targets as a reference vector and then calculate the cosine similarity between this reference and each individual target. If one gene exhibits distinctly higher similarity than the others, designate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['LDHC', 'MT-ND3', 'ZMIZ1-AS1', 'B3GAT3', 'MFSD14B']",rheumatoid arthritis,naive thymus derived cd4 positive alpha beta t cell,MT-ND3,"Which gene among LDHC, MT-ND3, ZMIZ1-AS1, B3GAT3, and MFSD14B exhibits the highest cell-type specificity in naïve thymus-derived CD4+ αβ T cells for targeting rheumatoid arthritis?","Which gene among LDHC, MT-ND3, ZMIZ1-AS1, B3GAT3, and MFSD14B exhibits the highest cell-type specificity in naïve thymus-derived CD4+ αβ T cells for targeting rheumatoid arthritis? Identify validated therapeutic targets for rheumatoid arthritis and extract their cell-type–specific embeddings from PINNACLE. Next, determine which genes from the naive thymus-derived CD4+ alpha-beta T cell activation set in PINNACLE overlap with these therapeutic targets, forming the cell-type–specific target set for rheumatoid arthritis. Calculate the average embedding of this overlapping set as a reference, then compute the cosine similarity between this reference and each individual target gene. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['NUTM2B', 'ZNHIT6', 'RPLP1', 'MCCC1-AS1', 'DNAJA4']",rheumatoid arthritis,naive thymus derived cd4 positive alpha beta t cell,RPLP1,"Among the genes NUTM2B, ZNHIT6, RPLP1, MCCC1-AS1, and DNAJA4, which one exhibits the highest cell-type specificity in naive thymus-derived CD4+ αβ T cells for potential targeting in rheumatoid arthritis?","Among the genes NUTM2B, ZNHIT6, RPLP1, MCCC1-AS1, and DNAJA4, which one exhibits the highest cell-type specificity in naive thymus-derived CD4+ αβ T cells for potential targeting in rheumatoid arthritis? Identify the validated therapeutic targets for rheumatoid arthritis and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which genes from the naive thymus-derived CD4+ alpha-beta T cell–activated gene set in PINNACLE overlap with these targets. Compute the average embedding of the overlapping genes and calculate the cosine similarity between this average and each individual target’s embedding. If one gene exhibits a notably higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['STK11IP', 'TARBP1', 'THSD7A', 'IKZF1', 'TARDBP']",rheumatoid arthritis,naive thymus derived cd4 positive alpha beta t cell,IKZF1,"Which gene among STK11IP, TARBP1, THSD7A, IKZF1, and TARDBP demonstrates the highest cell-type specificity in naive thymus-derived CD4+ alpha beta T cells for targeting rheumatoid arthritis?","Which gene among STK11IP, TARBP1, THSD7A, IKZF1, and TARDBP demonstrates the highest cell-type specificity in naive thymus-derived CD4+ alpha beta T cells for targeting rheumatoid arthritis? Identify validated therapeutic targets for rheumatoid arthritis and obtain their cell-type-specific embeddings from PINNACLE. Next, from the set of genes activated in naive thymus-derived CD4+ αβ T cells available in PINNACLE, determine the overlap with these therapeutic targets. Compute the average embedding of the overlapping genes and then calculate the cosine similarity between this average embedding and each individual target embedding. If one gene exhibits a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['MGST1', 'COX4I1', 'CXXC5', 'ZNF101', 'TRGV5P']",rheumatoid arthritis,naive thymus derived cd4 positive alpha beta t cell,COX4I1,"Among the genes MGST1, COX4I1, CXXC5, ZNF101, and TRGV5P, which one exhibits the highest cell-type specificity in naïve thymus-derived CD4+ αβ T cells, making it the most promising target for rheumatoid arthritis intervention?","Among the genes MGST1, COX4I1, CXXC5, ZNF101, and TRGV5P, which one exhibits the highest cell-type specificity in naïve thymus-derived CD4+ αβ T cells, making it the most promising target for rheumatoid arthritis intervention? Identify the verified rheumatoid arthritis therapeutic targets in PINNACLE and extract their cell-type–specific embeddings. Determine the overlap between these targets and the naive, thymus-derived, CD4-positive, αβ T cell–activated genes available in PINNACLE. For the overlapping set, calculate the average embedding to serve as a reference and compute the cosine similarity between this reference and each individual target gene embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['BICRAL', 'DDX6', 'CD300LB', 'RFC1', 'PRSS16']",rheumatoid arthritis,naive thymus derived cd4 positive alpha beta t cell,DDX6,"Which gene among BICRAL, DDX6, CD300LB, RFC1, and PRSS16 exhibits the highest cell-type specificity in naïve thymus-derived CD4+ αβ T cells, indicating its potential as the most promising target for rheumatoid arthritis therapy?","Which gene among BICRAL, DDX6, CD300LB, RFC1, and PRSS16 exhibits the highest cell-type specificity in naïve thymus-derived CD4+ αβ T cells, indicating its potential as the most promising target for rheumatoid arthritis therapy? Identify the validated therapeutic targets for rheumatoid arthritis and obtain their cell-type–specific embeddings from PINNACLE. Next, determine the intersection between these targets and the activated gene set from naive, thymus-derived CD4+ alpha-beta T cells available in PINNACLE. Compute the average embedding of the overlapping genes and calculate the cosine similarity between this reference and each individual target. If one gene exhibits a significantly higher similarity compared to the others, designate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ASMT_ENSG00000196433', 'HLA-E', 'SNHG22', 'UBL7', 'RGPD2']",rheumatoid arthritis,naive thymus derived cd4 positive alpha beta t cell,HLA-E,"Which gene among ASMT_ENSG00000196433, HLA-E, SNHG22, UBL7, and RGPD2 exhibits the highest cell-type specificity in naive thymus-derived CD4+ alpha beta T cells for potential targeting in rheumatoid arthritis?","Which gene among ASMT_ENSG00000196433, HLA-E, SNHG22, UBL7, and RGPD2 exhibits the highest cell-type specificity in naive thymus-derived CD4+ alpha beta T cells for potential targeting in rheumatoid arthritis? Identify the verified therapeutic targets for rheumatoid arthritis and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which naive thymus-derived CD4+ alpha–beta T cell–activated genes in PINNACLE overlap with these targets, thereby defining the cell-type–specific targets for rheumatoid arthritis. Calculate the average embedding of these overlapping genes and then compute the cosine similarity between this average and each individual target’s embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MIIP', 'TRMT12', 'SESN3', 'CASP6', 'MSL1']",rheumatoid arthritis,naive thymus derived cd4 positive alpha beta t cell,SESN3,"Which gene—MIIP, TRMT12, SESN3, CASP6, or MSL1—displays the most specific expression in naive thymus-derived CD4+ αβ T cells for the potential targeting of rheumatoid arthritis?","Which gene—MIIP, TRMT12, SESN3, CASP6, or MSL1—displays the most specific expression in naive thymus-derived CD4+ αβ T cells for the potential targeting of rheumatoid arthritis? Using the PINNACLE database, first identify the verified therapeutic targets for rheumatoid arthritis and retrieve their cell-type–specific embeddings. Next, from the naive thymus-derived CD4+ alpha beta T cell–activated gene set in PINNACLE, select the genes that overlap with these rheumatoid arthritis targets. For this overlapping set, calculate the average embedding to establish a reference, then compute the cosine similarity between this reference and the embedding of each individual gene. If one gene shows substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['STRBP', 'TAL2', 'EIF4A1', 'PTPRC', 'RRAGA']",rheumatoid arthritis,naive thymus derived cd4 positive alpha beta t cell,PTPRC,"Among the genes STRBP, TAL2, EIF4A1, PTPRC, and RRAGA, which one exhibits the highest cell-type specificity in naive thymus-derived CD4+ αβ T cells for targeting rheumatoid arthritis?","Among the genes STRBP, TAL2, EIF4A1, PTPRC, and RRAGA, which one exhibits the highest cell-type specificity in naive thymus-derived CD4+ αβ T cells for targeting rheumatoid arthritis? Identify the validated therapeutic targets for rheumatoid arthritis and retrieve their cell-type–specific embeddings from PINNACLE. Then, determine the overlap between these targets and the naive thymus-derived CD4-positive αβ T cell–activated genes in PINNACLE. Compute the average embedding of this overlapping set as a reference, and calculate the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ZNF573', 'LTB', 'CCDC138', 'DENND10', 'PROSER2-AS1']",rheumatoid arthritis,naive thymus derived cd4 positive alpha beta t cell,LTB,"Which gene among ZNF573, LTB, CCDC138, DENND10, and PROSER2-AS1 exhibits the highest specificity for naive thymus-derived CD4+ alpha-beta T cells, making it the most promising candidate for targeting rheumatoid arthritis?","Which gene among ZNF573, LTB, CCDC138, DENND10, and PROSER2-AS1 exhibits the highest specificity for naive thymus-derived CD4+ alpha-beta T cells, making it the most promising candidate for targeting rheumatoid arthritis? Identify the verified therapeutic targets for rheumatoid arthritis using PINNACLE, and retrieve their cell-type–specific embeddings. Next, determine which genes, activated in naive thymus-derived CD4+ alpha-beta T cells and present in PINNACLE, overlap with these targets to define a set of cell-type–specific rheumatoid arthritis targets. Compute the average embedding for this overlapping set and calculate the cosine similarity between this average and each individual gene’s embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SCAI', 'RPS26', 'MFAP1', 'EFCC1', 'DPM1']",rheumatoid arthritis,naive thymus derived cd4 positive alpha beta t cell,RPS26,"Which gene among SCAI, RPS26, MFAP1, EFCC1, and DPM1 demonstrates the highest cell-type specificity in naive thymus-derived CD4+ αβ T cells for targeted rheumatoid arthritis interventions?","Which gene among SCAI, RPS26, MFAP1, EFCC1, and DPM1 demonstrates the highest cell-type specificity in naive thymus-derived CD4+ αβ T cells for targeted rheumatoid arthritis interventions? Identify the verified therapeutic targets for rheumatoid arthritis and extract their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the naive thymus-derived CD4+ alpha-beta T cell activated genes from PINNACLE to derive the set of cell-type–specific targets for rheumatoid arthritis. Compute the average embedding of this overlapping set as a reference and then calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['APOBEC2', 'ZBTB8B', 'ARRDC2', 'LINC01307', 'CD52']",rheumatoid arthritis,naive thymus derived cd4 positive alpha beta t cell,CD52,"Among APOBEC2, ZBTB8B, ARRDC2, LINC01307, and CD52, which gene exhibits the highest cell-type specificity in naive thymus-derived CD4+ alpha-beta T cells for targeted rheumatoid arthritis therapy?","Among APOBEC2, ZBTB8B, ARRDC2, LINC01307, and CD52, which gene exhibits the highest cell-type specificity in naive thymus-derived CD4+ alpha-beta T cells for targeted rheumatoid arthritis therapy? Identify the validated therapeutic targets for rheumatoid arthritis and obtain their cell-type–specific embeddings from PINNACLE. Next, among the genes associated with the activation of naive thymus-derived CD4+ αβ T cells in PINNACLE, determine which overlap with the rheumatoid arthritis targets. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between the reference and each individual target. If one gene exhibits a markedly higher cosine similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ZNF385C', 'TNFAIP3', 'SUV39H2', 'ZBTB26', 'TFAP2A']",rheumatoid arthritis,naive thymus derived cd4 positive alpha beta t cell,TNFAIP3,"Among the genes ZNF385C, TNFAIP3, SUV39H2, ZBTB26, and TFAP2A, which one exhibits the highest cell-type specificity in naive thymus-derived CD4+ αβ T cells for targeting rheumatoid arthritis?","Among the genes ZNF385C, TNFAIP3, SUV39H2, ZBTB26, and TFAP2A, which one exhibits the highest cell-type specificity in naive thymus-derived CD4+ αβ T cells for targeting rheumatoid arthritis? For a set of verified therapeutic targets for rheumatoid arthritis with available cell-type–specific embeddings in PINNACLE, identify the overlapping genes with those expressed in naive thymus-derived, CD4+ alpha-beta T cells. Compute the average embedding of these overlapping genes and calculate the cosine similarity between this reference vector and the embedding of each individual target. If one gene exhibits a markedly higher cosine similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance in rheumatoid arthritis."
"['RPL3', 'RNF13', 'BCLAF1', 'NRBP2', 'ATXN3']",rheumatoid arthritis,naive thymus derived cd4 positive alpha beta t cell,RPL3,"Among the genes RPL3, RNF13, BCLAF1, NRBP2, and ATXN3, which one exhibits the highest cell-type specificity in naïve thymus-derived CD4⁺ αβ T cells, indicating its potential as a targeted candidate for rheumatoid arthritis therapy?","Among the genes RPL3, RNF13, BCLAF1, NRBP2, and ATXN3, which one exhibits the highest cell-type specificity in naïve thymus-derived CD4⁺ αβ T cells, indicating its potential as a targeted candidate for rheumatoid arthritis therapy? Identify the verified therapeutic targets for rheumatoid arthritis and obtain their cell type–specific embeddings from the PINNACLE database. Next, determine which genes associated with naive thymus‐derived CD4+ alpha-beta T cell activation in PINNACLE overlap with these targets. For this overlapping gene set, calculate the average embedding and then compute the cosine similarity between this reference vector and each individual target embedding. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['DDX6', 'ZNF324', 'C1QBP', 'RGS7', 'UBTD1']",rheumatoid arthritis,naive thymus derived cd4 positive alpha beta t cell,DDX6,"Among the genes DDX6, ZNF324, C1QBP, RGS7, and UBTD1, which one exhibits the highest cell-type specificity in naive thymus-derived CD4+αβ T cells for potential targeting in rheumatoid arthritis?","Among the genes DDX6, ZNF324, C1QBP, RGS7, and UBTD1, which one exhibits the highest cell-type specificity in naive thymus-derived CD4+αβ T cells for potential targeting in rheumatoid arthritis? Identify the validated therapeutic targets for rheumatoid arthritis and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the naive thymus-derived, CD4+ αβ T cell-activated genes in PINNACLE. For the overlapping set, compute the average embedding as a reference and calculate the cosine similarity between this reference and each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based rationale for its biological relevance."
"['RPLP1', 'POLDIP2', 'CHD8', 'CC2D1B', 'SLC30A8']",rheumatoid arthritis,naive thymus derived cd4 positive alpha beta t cell,RPLP1,"Among the genes RPLP1, POLDIP2, CHD8, CC2D1B, and SLC30A8, which one exhibits the highest cell-type specificity in naive thymus-derived CD4+ αβ T cells, thereby representing the most promising target for rheumatoid arthritis?","Among the genes RPLP1, POLDIP2, CHD8, CC2D1B, and SLC30A8, which one exhibits the highest cell-type specificity in naive thymus-derived CD4+ αβ T cells, thereby representing the most promising target for rheumatoid arthritis? Identify the validated therapeutic targets for rheumatoid arthritis and obtain their cell-type–specific embeddings from PINNACLE. Next, determine the intersection between these targets and the set of naive thymus-derived, CD4+ αβ T cell-activated genes in PINNACLE to define cell-type–specific targets for rheumatoid arthritis. Compute the average embedding of this intersecting set and calculate the cosine similarity between this average and each individual target embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MYEOV', 'CLSTN3', 'SESN3', 'TRAV1-2', 'ARHGAP44']",rheumatoid arthritis,naive thymus derived cd4 positive alpha beta t cell,SESN3,"Which gene among MYEOV, CLSTN3, SESN3, TRAV1-2, and ARHGAP44 exhibits the highest cell-type specificity in naive thymus-derived CD4+ alpha-beta T cells for targeting rheumatoid arthritis?","Which gene among MYEOV, CLSTN3, SESN3, TRAV1-2, and ARHGAP44 exhibits the highest cell-type specificity in naive thymus-derived CD4+ alpha-beta T cells for targeting rheumatoid arthritis? Identify verified therapeutic targets for rheumatoid arthritis and obtain their cell-type–specific embeddings from the PINNACLE database. Among these targets, determine which genes overlap with those identified as activated in naive, thymus-derived, CD4-positive αβ T cells in PINNACLE, thereby defining cell-type–specific targets. Compute the average embedding for this overlapping gene set as a reference, and then calculate the cosine similarity between this reference and each individual target's embedding. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate, providing a concise, evidence-based explanation of its biological relevance."
"['PPP1R27', 'RPL3', 'CYB561A3', 'UBE3C', 'EXOSC7']",rheumatoid arthritis,naive thymus derived cd4 positive alpha beta t cell,RPL3,"Among the genes PPP1R27, RPL3, CYB561A3, UBE3C, and EXOSC7, which one exhibits the greatest cell-type specificity in naive, thymus-derived CD4+ alpha-beta T cells, and may therefore serve as the most promising target for rheumatoid arthritis intervention?","Among the genes PPP1R27, RPL3, CYB561A3, UBE3C, and EXOSC7, which one exhibits the greatest cell-type specificity in naive, thymus-derived CD4+ alpha-beta T cells, and may therefore serve as the most promising target for rheumatoid arthritis intervention? Identify the verified therapeutic targets for rheumatoid arthritis and obtain their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the naive thymus–derived CD4+ alpha–beta T cell–activated genes in PINNACLE. Using the overlapping gene set, calculate an average embedding as a reference and compute the cosine similarity between this reference and each individual target’s embedding. If one gene exhibits a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PPP1R15B', 'MAP2K6', 'COX4I1', 'FAM89A', 'AHDC1']",rheumatoid arthritis,naive thymus derived cd4 positive alpha beta t cell,COX4I1,"Among PPP1R15B, MAP2K6, COX4I1, FAM89A, and AHDC1, which gene exhibits the highest cell-type specificity in naive thymus-derived CD4+ alpha-beta T cells, indicating its potential as a targeted therapeutic candidate for rheumatoid arthritis?","Among PPP1R15B, MAP2K6, COX4I1, FAM89A, and AHDC1, which gene exhibits the highest cell-type specificity in naive thymus-derived CD4+ alpha-beta T cells, indicating its potential as a targeted therapeutic candidate for rheumatoid arthritis? Identify the verified therapeutic targets for rheumatoid arthritis and retrieve their cell-type–specific embeddings from PINNACLE. Then, determine the overlap between these targets and the set of naive, thymus-derived, CD4+ alpha-beta T cell–activated genes in PINNACLE to define the cell-type-specific targets. Calculate the average embedding for this overlapping set and compute the cosine similarity between the average and each target gene. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['RBM34', 'IRF2', 'TMEM63C', 'NFKBIA', 'FAM30A']",rheumatoid arthritis,natural killer cell,NFKBIA,"Which gene among RBM34, IRF2, TMEM63C, NFKBIA, and FAM30A exhibits the highest cell-type specificity in natural killer cells for rheumatoid arthritis targeting?","Which gene among RBM34, IRF2, TMEM63C, NFKBIA, and FAM30A exhibits the highest cell-type specificity in natural killer cells for rheumatoid arthritis targeting? Identify all verified therapeutic targets for rheumatoid arthritis and retrieve their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which natural killer cell–activated genes in PINNACLE overlap with these targets. Compute the average embedding for this overlapping set and calculate the cosine similarity between this reference embedding and each individual target’s embedding. If one gene shows markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['RFXAP', 'ECRG4', 'GCSAML', 'PLPP6', 'HLA-C']",rheumatoid arthritis,natural killer cell,HLA-C,"Which gene among RFXAP, ECRG4, GCSAML, PLPP6, and HLA-C shows the most specific expression in natural killer cells and represents the best candidate for targeted intervention in rheumatoid arthritis?","Which gene among RFXAP, ECRG4, GCSAML, PLPP6, and HLA-C shows the most specific expression in natural killer cells and represents the best candidate for targeted intervention in rheumatoid arthritis? Identify the confirmed therapeutic targets for rheumatoid arthritis and extract their cell-type‐specific embeddings from PINNACLE. Next, determine which natural killer cell-activated genes in PINNACLE overlap with these targets to form a subset of cell-type–specific targets. Compute the average embedding of this subset as a reference, then calculate the cosine similarity between this reference and each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['JAK1', 'HEXD', 'WDR5B', 'MS4A7', 'DDX39B-AS1']",rheumatoid arthritis,natural killer cell,JAK1,"Among the following genes—JAK1, HEXD, WDR5B, MS4A7, and DDX39B-AS1—which exhibits the most cell type-specific expression in natural killer cells relevant for therapeutic targeting of rheumatoid arthritis?","Among the following genes—JAK1, HEXD, WDR5B, MS4A7, and DDX39B-AS1—which exhibits the most cell type-specific expression in natural killer cells relevant for therapeutic targeting of rheumatoid arthritis? Identify the validated therapeutic targets for rheumatoid arthritis and retrieve their cell-type–specific embeddings from PINNACLE. From these, determine which genes activated in natural killer cells (as identified in PINNACLE) overlap with the therapeutic targets. Compute the average embedding of this overlapping gene set and then calculate the cosine similarity between this average embedding and the embedding of each target gene. If one gene exhibits a significantly higher similarity score than the others, designate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TOP2A', 'MST1R', 'HEATR6-DT', 'PYGB', 'ACTB']",rheumatoid arthritis,natural killer cell,ACTB,"Which gene—TOP2A, MST1R, HEATR6-DT, PYGB, or ACTB—displays the highest natural killer cell–specific expression, making it the best candidate for targeting rheumatoid arthritis?","Which gene—TOP2A, MST1R, HEATR6-DT, PYGB, or ACTB—displays the highest natural killer cell–specific expression, making it the best candidate for targeting rheumatoid arthritis? Identify the validated therapeutic targets for rheumatoid arthritis and extract their cell-type–specific embeddings from PINNACLE. Next, determine which natural killer cell–activated genes in PINNACLE overlap with these targets, establishing a set of cell-type–specific rheumatoid arthritis targets. Calculate the average embedding for this overlapping set to serve as a reference, then compute the cosine similarity between this reference and the embedding for each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TTC9', 'TANC2', 'NOMO2', 'FOS', 'MED15']",rheumatoid arthritis,natural killer cell,FOS,"Among TTC9, TANC2, NOMO2, FOS, and MED15, which gene demonstrates the greatest cell-type specificity in natural killer cells in the context of rheumatoid arthritis?","Among TTC9, TANC2, NOMO2, FOS, and MED15, which gene demonstrates the greatest cell-type specificity in natural killer cells in the context of rheumatoid arthritis? Identify experimentally validated therapeutic targets for rheumatoid arthritis and obtain their cell-type-specific embeddings from the PINNACLE database. Next, determine which natural killer cell-activated genes in PINNACLE overlap with these targets, thereby defining the set of cell-type-specific targets. Compute the average embedding for this overlapping set as a reference, and then calculate the cosine similarity between the reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MAMDC2', 'ZNF341-AS1', 'JAK1', 'CPAMD8', 'SLC30A7']",rheumatoid arthritis,natural killer cell,JAK1,"Among the genes MAMDC2, ZNF341-AS1, JAK1, CPAMD8, and SLC30A7, which one exhibits the most specific expression in natural killer cells relevant to rheumatoid arthritis targeting?","Among the genes MAMDC2, ZNF341-AS1, JAK1, CPAMD8, and SLC30A7, which one exhibits the most specific expression in natural killer cells relevant to rheumatoid arthritis targeting? Identify the validated therapeutic targets for rheumatoid arthritis and retrieve their cell-type–specific embeddings from PINNACLE. Then, determine which of the natural killer cell–activated genes in PINNACLE overlap with these targets. For the overlapping set, compute the average embedding as a reference, and calculate the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['LINC01135', 'UVSSA', 'SDR42E1', 'NFKBIA', 'CLK4']",rheumatoid arthritis,natural killer cell,NFKBIA,"Which gene among LINC01135, UVSSA, SDR42E1, NFKBIA, and CLK4 exhibits the highest cell-type specificity in natural killer cells for targeting rheumatoid arthritis?","Which gene among LINC01135, UVSSA, SDR42E1, NFKBIA, and CLK4 exhibits the highest cell-type specificity in natural killer cells for targeting rheumatoid arthritis? For rheumatoid arthritis, identify the verified therapeutic targets and retrieve their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which of these targets overlap with the natural killer cell–activated genes in PINNACLE to define a set of cell-type–specific targets. Compute the average embedding for this set and calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['UNC5B', 'MCF2', 'ACTB', 'NUGGC', 'YIF1B']",rheumatoid arthritis,natural killer cell,ACTB,"Among the genes UNC5B, MCF2, ACTB, NUGGC, and YIF1B, which exhibits the highest natural killer cell-type specificity in the context of rheumatoid arthritis?","Among the genes UNC5B, MCF2, ACTB, NUGGC, and YIF1B, which exhibits the highest natural killer cell-type specificity in the context of rheumatoid arthritis? Identify validated therapeutic targets for rheumatoid arthritis and extract their cell-type-specific embeddings from PINNACLE. Next, determine which natural killer cell–activated genes in PINNACLE overlap with these targets to define cell-type-specific targets for the disease. Compute the average embedding of this overlap set, then calculate the cosine similarity between the average embedding and each individual embedding. If one gene displays a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance in rheumatoid arthritis."
"['ABCC5', 'FAM3C', 'FOS', 'TMEM244', 'TRBV25-1']",rheumatoid arthritis,natural killer cell,FOS,"Which gene among ABCC5, FAM3C, FOS, TMEM244, and TRBV25-1 demonstrates the highest natural killer cell–specific expression relevant to targeting rheumatoid arthritis?","Which gene among ABCC5, FAM3C, FOS, TMEM244, and TRBV25-1 demonstrates the highest natural killer cell–specific expression relevant to targeting rheumatoid arthritis? Identify the validated therapeutic targets for rheumatoid arthritis and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of the natural killer cell–activated genes in PINNACLE overlap with these targets to define the cell-type–specific RA targets. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance in rheumatoid arthritis."
"['FBXO8', 'RARA', 'HLA-C', 'ABHD1', 'CTSV']",rheumatoid arthritis,natural killer cell,HLA-C,"Which gene among FBXO8, RARA, HLA-C, ABHD1, and CTSV exhibits the highest cell-type specificity in natural killer cells for targeting rheumatoid arthritis?","Which gene among FBXO8, RARA, HLA-C, ABHD1, and CTSV exhibits the highest cell-type specificity in natural killer cells for targeting rheumatoid arthritis? Identify the validated therapeutic targets for rheumatoid arthritis and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine which targets overlap with the set of genes activated in natural killer cells, thereby defining the cell-type–specific targets relevant to rheumatoid arthritis. Compute the average embedding for these overlapping genes, and then calculate the cosine similarity between this average and the embedding of each individual target. If one gene demonstrates a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['JAK1', 'H2BC8', 'ADGRB2', 'OTUD1', 'CETN2']",rheumatoid arthritis,natural killer cell,JAK1,"Among the candidate genes JAK1, H2BC8, ADGRB2, OTUD1, and CETN2, which one exhibits the highest natural killer cell-specific expression relevant to targeting rheumatoid arthritis?","Among the candidate genes JAK1, H2BC8, ADGRB2, OTUD1, and CETN2, which one exhibits the highest natural killer cell-specific expression relevant to targeting rheumatoid arthritis? Identify the verified therapeutic targets for rheumatoid arthritis and extract their cell type–specific embeddings from PINNACLE. Next, determine which targets overlap with genes activated in natural killer cells to define a set of cell type–specific rheumatoid arthritis targets. Compute the average embedding for this overlapping set and calculate the cosine similarity between this reference vector and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['FOS', 'CLIP4', 'LINC01531', 'PSTK', 'ABCD2']",rheumatoid arthritis,natural killer cell,FOS,"Which gene among FOS, CLIP4, LINC01531, PSTK, and ABCD2 exhibits the highest specificity in natural killer cells for targeting rheumatoid arthritis?","Which gene among FOS, CLIP4, LINC01531, PSTK, and ABCD2 exhibits the highest specificity in natural killer cells for targeting rheumatoid arthritis? Identify the verified therapeutic targets for rheumatoid arthritis and obtain their corresponding cell-type–specific embeddings from PINNACLE. Then, determine which of these overlap with the natural killer cell–activated genes in PINNACLE to define the cell-type–specific targets. Compute the average embedding of this overlapping set, and calculate the cosine similarity between this reference and each individual target gene. Finally, if one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['AP2B1', 'PCNT', 'ASPHD1', 'NFKBIA', 'SPRY3']",rheumatoid arthritis,natural killer cell,NFKBIA,"Which gene among AP2B1, PCNT, ASPHD1, NFKBIA, and SPRY3 exhibits the highest cell-type specificity in natural killer cells, making it the most promising candidate for targeting rheumatoid arthritis?","Which gene among AP2B1, PCNT, ASPHD1, NFKBIA, and SPRY3 exhibits the highest cell-type specificity in natural killer cells, making it the most promising candidate for targeting rheumatoid arthritis? Identify the verified therapeutic targets for rheumatoid arthritis and extract their cell-type–specific embeddings from PINNACLE. Next, determine which natural killer cell-activated genes in PINNACLE overlap with these targets; this set represents the cell-type–specific targets for rheumatoid arthritis. Compute the average embedding of these genes as a reference, and then calculate the cosine similarity between this reference and each individual target. If one gene exhibits a distinctly higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based explanation for its biological relevance."
"['APOL4', 'CEND1', 'WIPI1', 'NAE1', 'HLA-C']",rheumatoid arthritis,natural killer cell,HLA-C,"Among APOL4, CEND1, WIPI1, NAE1, and HLA-C, which gene demonstrates the greatest specificity of expression in natural killer cells for potential therapeutic targeting of rheumatoid arthritis?","Among APOL4, CEND1, WIPI1, NAE1, and HLA-C, which gene demonstrates the greatest specificity of expression in natural killer cells for potential therapeutic targeting of rheumatoid arthritis? Using the verified therapeutic targets for rheumatoid arthritis, retrieve their cell-type–specific embeddings from PINNACLE. Identify the genes that overlap with natural killer cell-activated genes in the database, defining this subset as cell-type–specific targets. Compute the average embedding for these targets and calculate the cosine similarity between this average and each individual target. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ACTB', 'SGSM1', 'POLR3E', 'MGAT1', 'TMEM210']",rheumatoid arthritis,natural killer cell,ACTB,"Which gene among ACTB, SGSM1, POLR3E, MGAT1, and TMEM210 exhibits the highest specificity for natural killer cells and represents the most promising target for rheumatoid arthritis?","Which gene among ACTB, SGSM1, POLR3E, MGAT1, and TMEM210 exhibits the highest specificity for natural killer cells and represents the most promising target for rheumatoid arthritis? Using established therapeutic targets for rheumatoid arthritis and the cell-type specific embeddings from PINNACLE, identify the subset overlapping with natural killer cell-activated genes. Calculate the average embedding for these overlapping targets and determine the cosine similarity between this reference and each individual target. If one gene displays a significantly higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based explanation for its biological relevance."
"['ZNF212', 'MAP3K2-DT', 'JAK1', 'ZC2HC1A', 'SLIT2']",rheumatoid arthritis,natural killer cell,JAK1,"Which gene among ZNF212, MAP3K2-DT, JAK1, ZC2HC1A, and SLIT2 demonstrates the highest specificity for natural killer cells as a potential target in rheumatoid arthritis?","Which gene among ZNF212, MAP3K2-DT, JAK1, ZC2HC1A, and SLIT2 demonstrates the highest specificity for natural killer cells as a potential target in rheumatoid arthritis? Identify the verified therapeutic targets for rheumatoid arthritis and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of the natural killer cell–activated genes in PINNACLE overlap with these targets; designate this overlapping set as the rheumatoid arthritis cell-type–specific targets. Calculate the average embedding of this set and then compute the cosine similarity between this average and each individual target’s embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['HLA-C', 'ZNF213', 'C1QTNF2', 'NHLRC1', 'ROBO3']",rheumatoid arthritis,natural killer cell,HLA-C,"Among the candidate genes HLA-C, ZNF213, C1QTNF2, NHLRC1, and ROBO3, which gene exhibits the highest cell-type specificity in natural killer cells relevant to rheumatoid arthritis?","Among the candidate genes HLA-C, ZNF213, C1QTNF2, NHLRC1, and ROBO3, which gene exhibits the highest cell-type specificity in natural killer cells relevant to rheumatoid arthritis? Identify the validated therapeutic targets for rheumatoid arthritis and extract their cell-type–specific embeddings from PINNACLE. Next, among the natural killer cell-activated genes within PINNACLE, determine the subset that overlaps with these targets. Compute the average embedding of this overlapping set as a reference point, and then calculate the cosine similarity between this reference and each individual target gene. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PNRC2', 'ARL6', 'FOS', 'ZNF252P-AS1', 'A1BG-AS1']",rheumatoid arthritis,natural killer cell,FOS,"Among the genes PNRC2, ARL6, FOS, ZNF252P-AS1, and A1BG-AS1, which one exhibits the highest specificity in natural killer cells, making it the strongest candidate for targeting rheumatoid arthritis?","Among the genes PNRC2, ARL6, FOS, ZNF252P-AS1, and A1BG-AS1, which one exhibits the highest specificity in natural killer cells, making it the strongest candidate for targeting rheumatoid arthritis? Identify the validated therapeutic targets for rheumatoid arthritis and extract their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which natural killer cell-activated genes in PINNACLE overlap with these targets to define a set of cell-type–specific therapeutic candidates. Compute the average embedding for this overlapping set and then calculate the cosine similarity between this average and each individual target embedding. If one gene shows a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['USP43', 'MFF-DT', 'DTWD1', 'TSHZ2', 'ACTB']",rheumatoid arthritis,natural killer cell,ACTB,"Which gene among USP43, MFF-DT, DTWD1, TSHZ2, and ACTB exhibits the highest cell-type specificity in natural killer cells for targeting rheumatoid arthritis?","Which gene among USP43, MFF-DT, DTWD1, TSHZ2, and ACTB exhibits the highest cell-type specificity in natural killer cells for targeting rheumatoid arthritis? Identify the validated therapeutic targets for rheumatoid arthritis and extract their cell-type–specific embeddings from PINNACLE. Next, determine which natural killer cell–activated genes within PINNACLE overlap with these targets to compile a set of cell-type–specific targets. Compute the average embedding of this set and calculate the cosine similarity between the average reference and each individual target. If one gene displays a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NT5DC3', 'NFKBIA', 'WDR18', 'CDK7', 'TAS2R46']",rheumatoid arthritis,natural killer cell,NFKBIA,"Which gene among NT5DC3, NFKBIA, WDR18, CDK7, and TAS2R46 exhibits the highest specificity in natural killer cells, making it the most promising target for rheumatoid arthritis intervention?","Which gene among NT5DC3, NFKBIA, WDR18, CDK7, and TAS2R46 exhibits the highest specificity in natural killer cells, making it the most promising target for rheumatoid arthritis intervention? Identify the verified therapeutic targets for rheumatoid arthritis within the PINNACLE dataset and extract their cell-type–specific embeddings. Next, determine the overlap between these targets and the natural killer cell–activated genes represented in PINNACLE to define the cell-type–specific therapeutic targets. Calculate the average embedding of this overlapping gene set and then compute the cosine similarity between this average embedding and each individual target embedding. If one gene exhibits a significantly higher cosine similarity compared to all others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
